abdullah's picture
Add files using upload-large-folder tool
b4e65c0 verified
raw
history blame
57.7 kB
1
00:00:02,020 --> 00:00:06,140
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ูˆุงู„ุตู„ุงุฉ ูˆุงู„ุณู„ุงู… ุนู„ู‰ ุณูŠุฏ
2
00:00:06,140 --> 00:00:11,320
ุงู„ุฎู„ู‚ ุฃุฌู…ุนูŠู† ู†ู†ุชู‚ู„ ุงู„ูŠูˆู… ุฅู† ุดุงุก ุงู„ู„ู‡ ุฅู„ู‰ ุงู„ุฌุฒุก
3
00:00:11,320 --> 00:00:20,940
ุงู„ูƒู„ูŠู†ูŠูƒูŠ ู…ู† ุงู„ู…ู†ุงุนุฉ ูˆูŠุจุฏุฃ ุจุฃูˆู„ ู‡ุฐู‡ ุงู„ุฃู…ุฑุงุถ ูˆู‡ูˆ ุงู„
4
00:00:20,940 --> 00:00:26,140
hypersensitivity reaction ุงู„ู€ hypersensitivity
5
00:00:26,140 --> 00:00:30,540
ุชุนุฑูŠูุง ู‡ูŠ ุจุจุณุงุทุฉ ุญุงู„ุฉ ุจูŠุตูŠุฑ ููŠู‡ุง over reactivity ู„ู„
6
00:00:30,540 --> 00:00:38,740
immune response ูˆู‡ุฐุง ูŠุคุฏูŠ ุฅู„ู‰ deleterious ุจู…ุนู†ู‰
7
00:00:38,740 --> 00:00:45,420
ุจูŠุคุฏูŠ ุฅู„ู‰ ุฃุฐูŠุฉ ูˆู„ูŠุณ ุฅู„ู‰ ู†ุธุงู… ุญู…ุงูŠุฉ ููŠ ุงู„ุฌุณู… ุจูŠุตูŠุฑ
8
00:00:45,420 --> 00:00:47,260
ุงู„ู€ immune response
9
00:00:49,670 --> 00:00:58,770
ู…ู† ู…ุถุงุนูุงุชู‡ ุฃู†ู‡ ูŠุตูŠุฑ ููŠู‡ damage ูˆูŠุตูŠุฑ ููŠู‡
10
00:00:58,770 --> 00:01:03,990
pain ูˆูŠุตูŠุฑ ููŠู‡ ูƒู„ ุงู„ู€ inflammatory signs ุจูŠุนุงู†ูŠ
11
00:01:03,990 --> 00:01:13,990
ู…ู†ู‡ุง ุงู„ู…ุฑูŠุถ ุฃู†ูˆุงุน ุงู„ู€ hypersensitivity ู‡ู… ุฃุฑุจุนุฉ
12
00:01:13,990 --> 00:01:21,230
ุฃู†ูˆุงุน ุณู…ูˆู‡ู… ุฃูุนุทูˆู‡ู… ุฃุฑู‚ุงู… type 1 ูˆtype 2 ูˆtype 3
13
00:01:21,230 --> 00:01:26,870
ูˆtype 4 ุงู„ู„ูŠ ุนุฑูู‡ู… ุนู„ู‰ two scientists ูˆุงุญุฏ ุงุณู…ู‡
14
00:01:26,870 --> 00:01:33,330
ูƒูˆู…ุณ ูˆุงู„ุซุงู†ูŠ ุงุณู…ู‡ ุฌูŠู„ ุงู„ู†ูˆุน ุงู„ุฃูˆู„ ุณู…ูˆู‡ immediate
15
00:01:33,330 --> 00:01:40,050
hypersensitivity allergy ูˆู‡ูˆ ุจุจุณุงุทุฉ IgE mediated
16
00:01:40,050 --> 00:01:46,930
reaction ุจู…ุนู†ู‰ ุฃู† ููŠ antibody mediated the reaction
17
00:01:46,930 --> 00:01:52,590
ูˆู‡ุฐุง ุงู„ุฃู†ุชูŠุจูˆุฏูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† IgE Antibody It's
18
00:01:52,590 --> 00:01:58,230
stimulated the reaction is stimulated by the IgE
19
00:01:58,230 --> 00:02:05,650
ูŠูˆู… ูŠุฑุชุจุท ุจุฑุณูŠุจุชูˆุฑ ุชุจุนู‡ ุนู„ู‰ ุณุทุญ ุงู„ู…ุงุณุช ุณูŠู„ ูˆุงู„ุจูŠุฒูˆููŠู„
20
00:02:05,650 --> 00:02:10,450
ูˆุงู„ุฑูŠุณูŠุจุชูˆุฑ ู‡ูˆ ุนุจุงุฑุฉ ุนู† FC ุงุฑุชุจุงุทู‡ ู…ู† ุฎู„ุงู„ ุงู„ู€ FC
21
00:02:10,450 --> 00:02:13,430
portion of
22
00:02:16,350 --> 00:02:21,650
antibody ูŠุนู†ูŠ ุงู„ู„ูŠ ููŠ ุงู„ุชูˆุจ ุจูŠุธู„ ุงู„ูุงุจ ูˆุงู„ู€ receptor
23
00:02:21,650 --> 00:02:28,250
ุจูŠุณู…ูˆู‡ FC epsilon R1 once
24
00:02:28,250 --> 00:02:34,650
cross linked okay ุจู…ุนู†ู‰ ุงู„ู€ antigen ุตุงุฑูˆุง cross
25
00:02:34,650 --> 00:02:38,790
linking two antigen two antibody are cross linked
26
00:02:38,790 --> 00:02:44,560
with the same antigen ุงู„ู€ IgE ุจูŠุนู…ู„ ุชุญุฐูŠุฑ ู„ู„ู…ุงุณุช ุณูŠู„
27
00:02:44,560 --> 00:02:47,400
ูˆุงู„ุจูŠุฒูˆููŠู„ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„
28
00:02:47,400 --> 00:02:47,740
ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡
29
00:02:47,740 --> 00:02:49,760
ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ
30
00:02:49,760 --> 00:02:52,220
ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„
31
00:02:52,220 --> 00:02:52,260
ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡
32
00:02:52,260 --> 00:02:55,420
ุจุดูƒู„
33
00:02:55,420 --> 00:02:59,420
ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡ ุจุดูƒู„ ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ ู„ุชุญุฐูŠุฑู‡
34
00:02:59,420 --> 00:03:05,980
ุจุดูƒู„
35
00:03:05,980 --> 00:03:16,560
ุฏูŠุฌุฑุงู†ูŠูˆู„ูŠูƒูŠ be away from protection ูŠุนู†ูŠ ุงู„ู…ุฑูŠุถ ุจูŠูƒูˆู† ุฏุฎู„
36
00:03:16,560 --> 00:03:23,260
ููŠ ู…ุฑุญู„ุฉ ุฎุงุทุฑุฉ reaction usually is rapid ุจูŠุตูŠุฑ
37
00:03:23,260 --> 00:03:27,700
within minutes after challenge ุจู…ุนู†ู‰ after the
38
00:03:27,700 --> 00:03:35,680
exposure to the antigen type two ุจูŠุณู…ูˆู‡ cytolytic or
39
00:03:35,680 --> 00:03:41,980
cytotoxic reaction or cure ูˆู‡ูˆ ุทุจุนุง ุฃูŠุถุง antibody
40
00:03:41,980 --> 00:03:46,420
mediated ูŠูˆู… ูŠูƒูˆู† ุงู„ู€ IGM ุฃูˆ ุงู„ู€ IGE ูŠุฑุชุจุท ุจุงู†ุชุฌู†
41
00:03:46,420 --> 00:03:49,980
ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ูˆู‡ูˆ ุจูŠู†ุดุท ู„ู†ุง complement ูˆุงู„ู€
42
00:03:49,980 --> 00:03:56,780
complement ุจุชูƒุณุฑ ุงู„ุฎู„ูŠุฉ ุงู„ู„ูŠ ุงุชู†ุดุทุช ุนู„ูŠู‡ุง type 3
43
00:03:56,780 --> 00:04:03,280
ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ immune complex formation ุจู…ุนู†ู‰
44
00:04:03,280 --> 00:04:07,980
Immune Complex Reaction ุจูŠุตูŠุฑ ูˆุจุชุชุฌู…ุน ุงู„ู€ Immune
45
00:04:07,980 --> 00:04:12,120
ุจุงู„ุงู†ุชุฌู† ุทุจุนุง ูˆุงู„ู€ IGM ูˆุงู„ู€ IGG ุฃูŠุถุง Antibody
46
00:04:12,120 --> 00:04:17,440
Mediated ุจุชุจุฏุฃ ุชุชุฌู…ุน ู‡ุฐู‡ ุงู„ู€ Complexes in
47
00:04:17,440 --> 00:04:21,980
circulation or in tissue ูˆุจุฑุถู‡ ุจู†ุดุทู‡ ุงู„ู€ complement
48
00:04:21,980 --> 00:04:28,040
ุฃูŠุถุง ุงู„ู€ Granulocyte ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ is recruited is
49
00:04:28,040 --> 00:04:30,860
attracted to the site of vaccination ุฃูˆ of
50
00:04:30,860 --> 00:04:36,090
activation ูˆู‡ูŠ ุฃูŠุถุง ุจูŠุคุฏูŠ ุฅู„ู‰ damage of tissue by
51
00:04:36,090 --> 00:04:40,590
the enzyme from granulocytes and this also occur
52
00:04:40,590 --> 00:04:48,390
within hours from challenge with antigen ู†ูˆุน
53
00:04:48,390 --> 00:04:53,810
ุงู„ุฑุงุจุน cell mediated ูŠุนู†ูŠ ุงู„ุชู„ุงุชุฉ ุงู„ุฃูˆู„ุงู†ูŠูŠู† ู‡ู…
54
00:04:53,810 --> 00:04:57,310
ุนุจุงุฑุฉ ุนู† antibody mediated ุจูŠู†ู…ุง ุงู„ุฑุงุจุน ู‡ูˆ ุนุจุงุฑุฉ
55
00:04:57,310 --> 00:05:01,800
ุนู† cell mediated immunity ูˆุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ delete
56
00:05:01,800 --> 00:05:08,820
type hypersensitivity reaction ุงู„ู…ุญุตู„ุฉ ู†ุดุงุท ู„ู€ CD4
57
00:05:08,820 --> 00:05:16,480
T-Helper cell ูˆ CD8 cytotoxic cell ุฃูŠุถุง ู„ู…ุง ุชุชู†ุดุท
58
00:05:16,480 --> 00:05:21,000
ุงู„ู€ CD4 T-Helper cell ุจุชู†ุดุท ู„ู†ุง ุงู„ู€ different
59
00:05:21,000 --> 00:05:25,580
cytokine which recruit and activate macrophage
60
00:05:25,580 --> 00:05:29,320
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู€ macrophage ุจูŠุนู…ู„ damage ุฃูŠุถุง
61
00:05:32,950 --> 00:05:37,170
Tissue ุจุณ ุงู„ู€ reaction ุจูŠุตูŠุฑ within days or weeks
62
00:05:37,170 --> 00:05:41,010
after challenge with antigen ู„ุฃู†ู‡ ู…ู† ู‡ุฐุง ุงู„ู…ุทู„ู‚
63
00:05:41,010 --> 00:05:46,950
ุจูŠุณู…ูˆู‡ุง delayed type hypersensitivity reaction ู†ุจุฏุฃ
64
00:05:46,950 --> 00:05:49,850
ุจุฃูˆู„ ู‡ุฐู‡ ุงู„ุฃู†ูˆุงุน ูˆู†ุญูƒูŠ ููŠ type one
65
00:05:49,850 --> 00:05:55,350
hypersensitivity reaction ูˆู†ุญูƒูŠ ุจุงู„ู€ phases of
66
00:05:55,350 --> 00:06:00,010
allergic reaction ูŠุนู†ูŠ this reaction usually have
67
00:06:00,010 --> 00:06:03,230
three phases ุงู„ู€ phase ุงู„ุฃูˆู„ุงู†ูŠ ุจูŠุณู…ูˆู‡
68
00:06:03,230 --> 00:06:08,450
sensitization phase sensitization phase ุจู…ุนู†ู‰ ุฃู†ู‡
69
00:06:08,450 --> 00:06:14,930
ุชูƒูˆู† ุงู„ู€ IgE ุชูƒูˆู† ุงู„ู€ IgE in response to antigenic
70
00:06:14,930 --> 00:06:18,950
stimulus ูˆุงุฑุชุจุท ููŠ ุงู„ู€ receptor ุชุจุนู‡ ุนู„ู‰ ุณุทุญ ุงู„ู…ุงุณุช ุณูŠู„
71
00:06:18,950 --> 00:06:25,030
ูˆุงู„ุจูŠุฒูˆููŠู„ ูŠุนู†ูŠ ูู‚ุท ุชูƒูˆู† ุงู„ู€ IgE ุงู„ู€ antibody ูˆุฌุงุนุฏ
72
00:06:25,030 --> 00:06:30,610
ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ู…ู† ุฎู„ุงู„ ุงุฑุชุจุงุทู‡ ุจุงู„ู€ receptor ุชุจุนู‡
73
00:06:32,190 --> 00:06:37,710
ุงู„ูุงุฒ ุงู„ุซุงู†ูŠ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ activation phase ุทุจุนุง upon
74
00:06:37,710 --> 00:06:43,390
the exposure to the same antigen it will trigger
75
00:06:43,390 --> 00:06:48,030
ูˆุงุฑุชุจุงุท ุงู„ู€ antibody ุจู‡ุฐุง ุงู„ู€ antigen it will
76
00:06:48,030 --> 00:06:54,830
trigger mast cell and basophil to respond ูˆุงู„ู€ the
77
00:06:54,830 --> 00:06:59,230
response ูŠุนู†ูŠ ุฃู†ู‡ they degranulate they release
78
00:06:59,230 --> 00:07:04,350
their granules ุงู„ู€ Phase ุงู„ุซุงู„ุซ ูˆู‡ูˆ ุงู„ู€ Effect of
79
00:07:04,350 --> 00:07:07,910
Phase ูˆู‡ูˆ ุชุฃุซูŠุฑ ุงู„ู€ Granules ุดูˆ ุจูŠุนู…ู„ุŸ Complex
80
00:07:07,910 --> 00:07:14,050
Response ู„ุฃู†ู‡ ููŠ ู…ุฌู…ูˆุนุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ู€ Granules
81
00:07:14,050 --> 00:07:19,150
ุจุชุทู„ุน ูƒู„ ูˆุงุญุฏ ู„ู‡ Effect ู…ุนูŠู† ูุงู„ู…ุญุตู„ุฉ ู‡ูˆ ุนุจุงุฑุฉ ุนู†
82
00:07:19,150 --> 00:07:22,950
Complex Response ู…ู† ุงู„ู€ ... ุจูŠุคุฏูŠ ุฅู„ู‰ Many
83
00:07:22,950 --> 00:07:28,850
Inflammatory Reactions ุจุณุจุจ ุฅุทู„ุงู‚ ุงู„ูƒุซูŠุฑ ู…ู†
84
00:07:28,850 --> 00:07:35,650
ุงู„ู€ inflammatory mediators ุจุดูƒู„ ู…ุงุณุช ุณูŠู„ ูˆุจูŠุฒูˆููŠู„ ุทุจุนุง
85
00:07:35,650 --> 00:07:41,570
ู…ุง ุญุตู„ุช ู‡ุฐุง ุงู„ูƒู„ุงู… ุฃู† ู‡ู†ุงูƒ ุฃุนุฑุงุถ ูˆุงู„ุฃุนุฑุงุถ ุจุชุธู‡ุฑ
86
00:07:41,570 --> 00:07:49,200
ุจุฅูƒุฒูŠู…ุฉ ูˆุฃุฒู…ุฉ ูˆุฑูŠู†ูŠุชุณ ูˆู‡ูƒุฐุง ุทูŠุจ ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ
87
00:07:49,200 --> 00:07:52,220
ููŠ ุงู„ู€ sensitization phaseุŸ ู‚ุงู„ูˆุง ุงู„ู€ immunoglobulin
88
00:07:52,220 --> 00:07:56,500
ู‡ูˆ ุงู„ู…ุณุคูˆู„ ุนู† ุงู„ู€ allergic reaction ูˆุงุชูู‚ู†ุง ุนู„ู‰ ุฃู†ู‡
89
00:07:56,500 --> 00:08:04,520
ู‡ูˆ ุงู„ู€ IGA it occurs usually by
90
00:08:04,520 --> 00:08:09,680
any means of contact ุจู…ุง ููŠู‡ุง skin contact or
91
00:08:09,680 --> 00:08:13,560
through injection or through injection of and
92
00:08:13,560 --> 00:08:21,080
inhalation to the antigen ููŠ ู…ุตุทู„ุญูŠู† ุจูŠุตุงุญุจูˆุง ู‡ุฐู‡
93
00:08:21,080 --> 00:08:27,340
ุงู„ุญุงู„ุฉ ุงู„ุฃูˆู„ุงู†ูŠ ู‡ูˆ ุงู„ู€ hay fever ูˆู‡ูˆ ู…ุตุทู„ุญ ู†ู‚ุตุฏ ููŠู‡
94
00:08:27,340 --> 00:08:34,700
ุฃู† ุงู„ุฃู†ุชุฌูŠู† ุฌุงุก from airborne allergen ุฃูˆ source ุงู„
95
00:08:34,700 --> 00:08:41,760
atopy ุฃูŠุถุง ุจูŠุนู†ูŠ ุฃู† ุงู„ู€ IGE related
96
00:08:41,760 --> 00:08:43,640
hypersensitivity reaction
97
00:08:47,060 --> 00:08:52,000
ูˆุงู„ู…ุฑุถู‰ ุงู„ู„ูŠ ุจูŠุณู…ูˆู‡ ุนู†ุฏู‡ู… ู‡ุฐุง ุงู„ู†ูˆุน ู…ู† ุงู„ู€ reaction
98
00:08:52,000 --> 00:09:00,020
ุจูŠุณู…ูˆู‡ู… atopic patient atopic patient ุงู„
99
00:09:00,020 --> 00:09:07,140
RGE response are genetically controlled ูˆุงู„ุฌูŠู†
100
00:09:07,140 --> 00:09:11,760
ุงู„ู„ูŠ ูŠู€ control the IGE antibody ู‡ู… ุนุจุงุฑุฉ ุนู† MHC
101
00:09:11,760 --> 00:09:16,120
linked gene ู…ูˆุฌูˆุฏูŠู† ุนู„ู‰ ูƒุฑูˆู…ูˆุณูˆู… ุฑู‚ู… 6 ุฃูŠุถุง
102
00:09:16,120 --> 00:09:20,100
control ู…ูˆุฌูˆุฏ
103
00:09:20,100 --> 00:09:24,400
ู…ู† ุฎู„ุงู„ other regulatory gene ุฒูŠ ุงู„ุฌูŠู†ุงุช ุงู„ู…ุณุคูˆู„ุฉ
104
00:09:24,400 --> 00:09:28,520
ุนู† ุงู„ู€ FCE receptor ูˆู‡ุฐุง ู…ูˆุฌูˆุฏูŠู† ุนู„ู‰ ูƒุฑูˆู…ูˆุณูˆู… ุฑู‚ู…
105
00:09:28,520 --> 00:09:34,640
2 ูƒู…ุงู† ุงู„ุฌูŠู†ุงุช ุงู„ู„ูŠ ู…ูˆุฌูˆุฏูŠู† for T ู„ู„ุจุฑุชูˆูƒูˆู„ and
106
00:09:34,640 --> 00:09:39,380
IL4 gene ูˆุทุจุนุง ู‡ุฏูˆู„ ู…ูˆุฌูˆุฏูŠู† ุนู„ู‰ ูƒุฑูˆู…ูˆุณูˆู… ุฑู‚ู… 5
107
00:09:40,600 --> 00:09:45,920
ุจูŠุญุชูˆูŠ ุนู„ู‰ ุนุฏุฉ ุฌูŠู†ุงุช ู…ู†ู‡ู… ุงู„ู„ูŠ ูŠูุฑู‚ ุขูŠุฉ 3 ุฃูˆ
108
00:09:45,920 --> 00:09:49,500
4 ุฃูˆ 5 ุฃูˆ 9 ุฃูˆ 13 ูˆุจุงู„ุชุงู„ูŠ ุนุจุงุฑุฉ ุนู†
109
00:09:49,500 --> 00:09:54,020
ู…ุฌู…ูˆุนุฉ ู…ู† ุงู„ุฌูŠู†ุงุช ุทุจุนุง over expression of these
110
00:09:54,020 --> 00:10:04,260
genes ุจูŠุนู†ูŠ ุฒูŠุงุฏุฉ ููŠ ู‡ุฐุง ุงู„ู†ูˆุน ู…ู† ุงู„ุญุณุงุณูŠุฉ ุงู„ู€
111
00:10:04,260 --> 00:10:09,440
IGE antibody production ุงุชูู‚ู†ุง ุนู„ู‰ ุฃู† ู‡ุฐู‡ ุงู„ู€ response
112
00:10:09,440 --> 00:10:14,210
dependent ูˆุจู…ุง ุฃู†ู†ุง ุจู†ุญูƒูŠ ุนู„ู‰ T helper 2 ูŠุจู‚ู‰
113
00:10:14,210 --> 00:10:19,150
IL4 ูˆIL13 ุณุงุนุชู‡ ูƒุงู† ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ู‡ุฐุง
114
00:10:19,150 --> 00:10:25,770
ุงู„ู…ูˆุถูˆุน ููŠ ุชู†ุดูŠุท T helper 2 ูˆู„ูˆ ุงุณุชุฎุฏู…ู†ุง Anti-IL
115
00:10:25,770 --> 00:10:33,370
-4 Antibody it will mimic and inhibit the IgE
116
00:10:33,370 --> 00:10:37,230
production ุฃูŠุถุง
117
00:10:38,850 --> 00:10:43,870
ูˆุฌุฏูˆุง ุฃู† ุงู„ู€ concentration of IL-4 ุฃูˆ level of IL-4
118
00:10:43,870 --> 00:10:49,350
ููŠ ู‡ุฏูˆู„ ุงู„ุฃุดุฎุงุต is higher than non allergic one
119
00:10:49,350 --> 00:10:54,950
ุฃูŠุถุง ุงู„ู€ IGE level are also higher than the first
120
00:10:54,950 --> 00:11:04,190
group ุงู„ู„ูŠ ู‡ูˆ IL-4 IL-13 group ุทุจุนุง
121
00:11:04,190 --> 00:11:06,050
once exposure to the allergen
122
00:11:09,990 --> 00:11:21,270
ุจุนุฏ ู…ุฑุงุฌุนุฉ ุซุงู†ูˆูŠุฉ ู…ุฑุฉุŒ ูŠุนุชุจุฑ ุงู„ุดุฎุต ู…ุณุชุดุนุฑุŒ ูˆุงู„ู€
123
00:11:21,270 --> 00:11:27,210
IgEุŒ ุนููˆุงุŒ ุจู…ุฌุฑุฏ ุฏุฎูˆู„ ุงู„ู€ AllergenุŒ ุงู„ู€ IgE ุจุชูƒูˆู†
124
00:11:27,210 --> 00:11:31,470
ุฃูˆ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ู…ู† ุฎู„ุงู„ ุงุฑุชุจุงุทู‡ ุจุงู„ู€
125
00:11:31,470 --> 00:11:36,760
Receptor ุชุจุนู‡.ุงู„ู…ุงุณุช ุณูŠู„ ุงู„ู„ูŠ ู†ุฌูŠุจู‡ุง ู…ูˆุฌูˆุฏุฉ ููŠ blood
126
00:11:36,760 --> 00:11:39,680
vessels around the blood vessels in the connective
127
00:11:39,680 --> 00:11:45,940
tissue ู…ูˆุฌูˆุฏุฉ lining the gut and in the lung
128
00:11:45,940 --> 00:11:49,620
ูˆู‡ุฐู‡ ุทุจุนุง ุงู„ุฃู…ุงูƒู† ุงู„ุญุณุงุณุฉ ุงู„ุชูŠ ุชุชุฃุซุฑ ูˆูŠุตูŠุฑ ููŠู‡ุง
129
00:11:49,620 --> 00:11:56,620
damage through the hypersensitivity reaction both
130
00:11:56,620 --> 00:12:00,540
muscle and basophil have the receptor ุงู„ู„ูŠ ู‡ูˆ ุงู„
131
00:12:00,540 --> 00:12:05,220
Fc epsilon receptor one which points to IgE ู…ู† ุฎู„ุงู„
132
00:12:05,220 --> 00:12:10,380
ุงู„ู€ Fc portion ู…ุงุดูŠ ูŠุนู†ูŠ ุงู„ู„ูŠ ูุงู„ุช ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ูŠุฉ
133
00:12:10,380 --> 00:12:16,280
ู‡ูˆ ุงู„ู€ Fab region and it will remain sensitized these
134
00:12:16,280 --> 00:12:21,780
cells will remain sensitized and their activation
135
00:12:21,780 --> 00:12:28,080
occurs when antigen comes in contact with them ูู‚ุท
136
00:12:28,080 --> 00:12:32,070
ูŠุนู†ูŠ ููŠ ุงู„ู…ุฑุฉ ุงู„ุฃูˆู„ุงู†ูŠุฉ ูู‚ุท ุงู„ุชุนุฑุถ ุงู„ุฃูˆู„ุงู†ูŠ
137
00:12:32,070 --> 00:12:36,510
ู„ู„ุงู†ุชูŠุฌูŠู† ูู‚ุท ุจูŠุชูƒูˆู† ุงู„ู€ antibody ูˆุจูŠู‚ุนุฏ ุนู„ู‰ ุณุทุญ
138
00:12:36,510 --> 00:12:40,490
ุงู„ุฎู„ุงูŠุง ูˆ ุจู†ุนุชุจุฑ ุงู„ู…ุฑูŠุถ sensitized upon second
139
00:12:40,490 --> 00:12:43,910
exposure to the same antigen ู‡ูŠูƒูˆู† ุงู„ู€ antibody
140
00:12:43,910 --> 00:12:48,270
ุฌุงู‡ุฒ ุจูŠุณุชู†ู‰ ุงู„ู€ antigen ูˆู„ู…ุง ูŠุญุตู„ cross linking
141
00:12:48,270 --> 00:12:49,410
ุจูŠุญุตู„ ููŠู‡ activation
142
00:12:52,370 --> 00:12:55,710
ุงู„ู€ Passive Sensitization is achieved by
143
00:12:55,710 --> 00:12:58,530
transferring ูŠุนู†ูŠ ู…ู…ูƒู† ุงู„ูˆุงุญุฏ ูŠุงุฎุฏ ุงู„ุญุณุงุณูŠุฉ ู…ู†
144
00:12:58,530 --> 00:13:03,590
ูˆุงุญุฏ ุซุงู†ูŠ ุทุจุนุง ุฅุฐุง ุฃุฎุฏ ู…ู†ู‡ Serum ูˆุจูŠุญุชูˆูŠ ุนู„ู‰ ุงู„ู€
145
00:13:03,590 --> 00:13:11,890
IgA Antibody to specific antigen ุจูŠุณู…ูˆ ุงู„ุนู…ู„ูŠุฉ
146
00:13:11,890 --> 00:13:18,330
Passive Sensitization ูˆู‡ุฐุง ู…ุง ูŠุญุฏุซ ููŠ Prausnitz
147
00:13:18,330 --> 00:13:24,760
Kรผstner Testุงู„ุฐูŠ ู…ู† ุฎู„ุงู„ู‡ ู†ุณุชุทูŠุน ู†ุญูƒูŠ ุงู„ู€ antibody
148
00:13:24,760 --> 00:13:28,700
responsible for anaphylactic reaction ูˆุงุญุฏ ุนู†ุฏู‡
149
00:13:28,700 --> 00:13:35,180
ุญุณุงุณูŠุฉ ุจู†ุนู…ู„ู‡ ุงู„ู€ PKA test ุงู„ู„ูŠ ู‡ูˆ Prausnitz Kรผstner
150
00:13:35,180 --> 00:13:42,660
Test ุจู†ุดูˆู ู…ู† ุฎู„ุงู„ู‡ ุฅู†ู‡ ููŠ ุนู†ุฏู‡ antibody which can
151
00:13:42,660 --> 00:13:48,120
cause anaphylactic reaction or not ุทุจุนุง ูƒู„ูƒู…
152
00:13:48,120 --> 00:13:52,050
ุชุนุฑููˆุง ุงู„ู€ TBreaction ุงู„ู„ูŠ ู‡ูˆ ุจูŠุนู…ู„ wheel
153
00:13:52,050 --> 00:13:58,290
and flare reaction ููŠ ุงู„ู€ skin ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠ ู‡ุฐุง
154
00:13:58,290 --> 00:14:05,350
ุงู„ูุญุต ุฅู†ู‡ ุงู„ุฅู†ุณุงู† ุงู„ู„ูŠ ุนู†ุฏู‡ allergy for x antigen
155
00:14:05,350 --> 00:14:09,830
ุจู†ุงุฎุฏ
156
00:14:09,830 --> 00:14:14,850
ู…ู†ู‡ ุงู„ู€ serum ูˆ ุจู†ุนู…ู„ู‡ injection into non allergic
157
00:14:14,850 --> 00:14:21,160
person ูุจูŠุตูŠุฑ ุนู†ุฏู‡ antibody ู…ู† ู†ูˆุน IgE ุงู„ุฐูŠู† ูŠู‚ูˆู…ูˆู†
158
00:14:21,160 --> 00:14:29,140
ุจุฅุฏุฎุงู„ mast cell ูˆbasophil ุทุจุนุง ู…ุฑุฉ ุฃู†ุชุฌุช ุจู€ antigen X
159
00:14:29,140 --> 00:14:35,120
ุณูŠุณุจุจ ููŠู‡ุง ุชูุงุนู„ ุงุฑุชูƒุงุฑูŠุงู„ ุทุจุนุง
160
00:14:35,120 --> 00:14:40,180
ู‡ุฐู‡ ุงู„ุชูุงุนู„ ู‡ูŠ ุญูŠุซ ุงู† ุงู„ุญูŠูˆุงู† ู…ุณุชุดุนุฑ ุจุดูƒู„ ู…ุณุชุดุนุฑ
161
00:14:40,180 --> 00:14:46,660
ู…ุณุชุดุนุฑ
162
00:14:47,880 --> 00:14:52,440
ู‡ูˆ ุจูŠุณู…ูˆู‡ุง ุงู„ุชูุงุนู„ passive cutaneous anaphylaxis
163
00:14:52,440 --> 00:14:57,240
ุฃู†ู‡ ุจูŠุตูŠุฑ ุนู„ู‰ ุงู„ู€ skin ู‡ูˆ ุฏู‡ ุจูŠุตูŠุฑ ุญู‚ุง ุชุญุช ุงู„ู€ skin
164
00:14:57,240 --> 00:15:00,760
ู‡ูˆ ุจูŠุตูŠุฑ ุนู„ู‰ ุงู„ู€ skin with and flare reaction
165
00:15:00,760 --> 00:15:08,600
ูˆุจูŠุณู…ูˆู‡ุง passive cutaneous anaphylaxis ูˆู‡ูŠ ุงู„ู€
166
00:15:08,600 --> 00:15:14,700
activation ุฒูŠ ู…ูŠู† ุฏูŠ ุนุจุงุฑุฉ ุนู† mast cell ุนู„ู‰ ุณุทุญู‡
167
00:15:14,700 --> 00:15:20,120
receptor ุฏู‡ ู‡ูˆ ุงู„ู€ receptor for IgE FcEpsilon-R1
168
00:15:20,120 --> 00:15:27,480
Receptor ุงุฑุชุจุท ููŠู‡ ุงู„ู€ antibody IgE ูˆุทุจุนุง ู‡ูŠ
169
00:15:27,480 --> 00:15:33,000
ุงู„ู€ antibody ูŠูˆู… ุฏุฎู„ ุงู„ู€ antigen ูˆุตุงุฑ cross linking
170
00:15:33,000 --> 00:15:39,440
ูŠุนู†ูŠ ู…ุณูƒุชูˆุง antibody ู…ุน ุจุนุถ ู†ุดุทุช ุงู„ู€ mast cell ูˆุนู…ู„ุช
171
00:15:39,440 --> 00:15:44,020
degranulation ู‡ูŠ ุงู„ู€ degranulation occurs ุจูˆุถูˆุญ ููŠ
172
00:15:44,020 --> 00:15:44,620
ู‡ุฐู‡ ุงู„ุญุงู„ุฉ
173
00:15:49,130 --> 00:15:52,530
ุงู„ู€ activation phase of allergic reaction ุจูŠุจุฏุฃ by
174
00:15:52,530 --> 00:15:56,350
triggering the mast cell to release their content and
175
00:15:56,350 --> 00:16:02,550
inflammatory mediators in
176
00:16:02,550 --> 00:16:07,370
the medium ุฃูŠุถุง it occurs it requires to at least
177
00:16:07,370 --> 00:16:13,550
two of the receptors of the Fc region of IgE
178
00:16:13,550 --> 00:16:17,270
molecule to be bridged ูŠุนู†ูŠ ู‚ู„ู†ุง ู„ูƒูˆุง ุจุฏู‡ ูŠุญุตู„ ููŠู‡
179
00:16:17,270 --> 00:16:21,670
cross-linking between two receptors ู…ู† ุฎู„ุงู„
180
00:16:21,670 --> 00:16:29,850
ุงุฑุชุจุงุทู‡ู… with one antigen ุงู„ู…ุญุตู„ุฉุŒ
181
00:16:29,850 --> 00:16:34,950
ุงู„ู…ุญุตู„ุฉ ุฅุซุงุฑุฉ ุงู„ูƒู„ุงู… ุฅู† ุงู„ู…ุญุตู„ุฉ ุงู„ู€ Degranulate ู‡ูˆ
182
00:16:34,950 --> 00:16:39,070
ุงู„ู€ Degranulation ุจูŠุนุชู…ุฏ ุงู„ู€ Inflammatory reaction
183
00:16:39,070 --> 00:16:43,150
ุจูŠุนุชู…ุฏ ุนู„ู‰ ุงู„ู€ dose of antigen and route of entry
184
00:16:43,150 --> 00:16:50,690
route of entry ูƒูŠู ุฏุฎู„ ุงู„ู€ antigen ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ if
185
00:16:50,690 --> 00:16:54,530
it degranulates in the GIT ูŠุนู†ูŠ gastrointestinal
186
00:16:54,530 --> 00:16:59,670
tract it will cause fluid secretion and
187
00:16:59,670 --> 00:17:05,750
peristalsis to occur ูˆุงู„ู…ุญุตู„ุฉ ุฅุณู‡ุงู„ ูˆ vomiting
188
00:17:06,740 --> 00:17:12,080
ูŠุนู†ูŠ ูˆุงุญุฏ ุนู†ุฏู‡ ุญุณุงุณูŠุฉ ุฏุฎู„ุช ุนู† ุทุฑูŠู‚ ุงู„ุฌุณุฏ ุงู„ุฃูƒู„ ู…ู…ูƒู†
189
00:17:12,080 --> 00:17:18,100
ูŠุตูŠุฑ ููŠู‡ ุงู„ู„ูŠ ู‡ูˆ ุฅุณู‡ุงู„ ูˆ ู†ุชุฌ ูˆ ุงู„ุฌู‡ุงุฒ ุงู„ู‡ุถู…ูŠ ู‡ูˆ ู…ู†
190
00:17:18,100 --> 00:17:23,980
ูŠุชุฃุซุฑ ููŠ ุงู„ู€ lung ุฅุฐุง ูƒุงู† by inhalation ู…ุงุดูŠ it
191
00:17:23,980 --> 00:17:30,020
decreases in airway diameter ูˆ ุจูŠุตูŠุฑ ููŠู‡ blockage
192
00:17:30,020 --> 00:17:35,180
of the airways ูŠุนู†ูŠ ุจุชุถูŠู‚
193
00:17:36,000 --> 00:17:44,020
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ airways diameter ูˆ ุจูŠุตูŠุฑ ููŠู‡ ุถูŠู‚ ููŠ
194
00:17:44,020 --> 00:17:48,980
ุงู„ุชู†ูุณ in blood vessels ู‡ุฐุง ุจูŠุนู…ู„ vascular
195
00:17:48,980 --> 00:17:52,980
permeability ูŠุจู‚ู‰ ุญุณุจ ุงู„ู…ูƒุงู† ุงู„ู„ูŠ ุฅูŠุด ุงู„ู„ูŠ ุตุงุฑ ููŠู‡
196
00:17:52,980 --> 00:17:57,960
ุงู„ู€ reaction ุจูŠุตูŠุฑ ููŠู‡ symptoms ู…ุตุงุญุจุฉ ู„ุฅูŠู‡
197
00:18:00,580 --> 00:18:08,920
ุญุณุจ ุงู„ู…ูƒุงู† ุจุชุฎุชู„ู ุจุงุฎุชู„ุงู ุงู„ู…ูƒุงู† ุทุจุนุง ุงู„ู€ severity
198
00:18:08,920 --> 00:18:14,480
ุจุชุฎุชู„ู ุจุงุฎุชู„ุงู ุงู„ู€ dose ูˆู‡ุฐู‡
199
00:18:14,480 --> 00:18:22,720
ุงู„ุตูˆุฑุฉ ุจูŠุจูŠู† ู„ู†ุง different ways ุงู„ู„ูŠ ู…ู† ุฎู„ุงู„ู‡ุง ุงู„ู€
200
00:18:22,720 --> 00:18:26,980
mast cell ูˆ ุงู„ู€ basophil ุนู…ู„ุช degranulation ูุฒูŠ ู…ุง
201
00:18:26,980 --> 00:18:32,070
ุฅู†ุชูˆุง ุดุงูŠููŠู† ุทุจุนุง ู‡ู†ุง ููŠ ุนู†ุฏู†ุง mast cell already
202
00:18:32,070 --> 00:18:36,750
sensitized ุนู„ู‰ ู†ูุณู‡ุง antibody ูŠูˆู… ูŠุตูŠุฑ ููŠ bridging
203
00:18:36,750 --> 00:18:41,270
between these two antibodies by even anti-IgE
204
00:18:41,270 --> 00:18:49,190
ู‡ูŠุตูŠุฑ ููŠ ุงู„ู€ degranulation ุฃูŠุถุง ู‡ู†ุง ู…ู…ูƒู† ูŠุตูŠุฑ ููŠ
205
00:18:49,190 --> 00:18:53,930
cross linking ู…ู† ุฎู„ุงู„ ุงู„ุงุฑุชุจุงุท ุจุงู„ู€ actin ู‡ู†ุง ู…ู† ุฎู„ุงู„
206
00:18:53,930 --> 00:18:59,750
ุงุฑุชุจุงุท ุจู€ chemical substance ูˆู‡ู†ุง ู…ู† ุฎู„ุงู„ ุงู„ุงุฑุชุจุงุท
207
00:18:59,750 --> 00:19:07,530
ุจู€ Anti-Receptor Antibody ุถุฏ ู…ูŠู‡ ุถุฏ ุงู„ู€ Receptor ุชุจุน
208
00:19:07,530 --> 00:19:16,630
ุงู„ู€ IgE-Epsilon ู‡ุฐู‡
209
00:19:16,630 --> 00:19:21,710
ุงู„ููŠุฌูˆุฑ ุงู„ู„ูŠ ูุงุช ุจูŠุจูŠู† ู„ู†ุง various types of cross
210
00:19:21,710 --> 00:19:25,950
linking which lead to mast cell degranulation
211
00:19:29,050 --> 00:19:32,970
ุฃูŠุถุง Calcium ionophore ุจูŠุคุฏูŠ ุฅู„ู‰ ุฒูŠุงุฏุฉ ุงู„ู€ calcium
212
00:19:32,970 --> 00:19:37,590
influx ููŠ ุงู„ุฎู„ูŠุฉ ูˆู‡ุฐุง ุจูŠุคุฏูŠ ุฅู„ู‰ ุงู„ู€ degranulation
213
00:19:37,590 --> 00:19:44,990
ุงู„ู€ anaphylatoxins C3A ูˆ C5A ูˆ Drugs ุฒูŠ ุงู„ู€ codeine
214
00:19:44,990 --> 00:19:50,210
ูˆ ุงู„ู€ morphine ูˆุจุนุถ ุงู„ู€ lectin ุฃูŠุถุง ูƒุงู† cross-linked
215
00:19:50,210 --> 00:19:58,850
IgE Fc receptor Receptor ุจูŠุณู…ู„ู‡ aggregation ูˆู‡ูˆ
216
00:19:58,850 --> 00:20:03,030
ุจูŠุบูŠุฑ ุดูƒู„ู‡ ูˆุจูŠุชุจู‘ุน
217
00:20:03,030 --> 00:20:08,070
ุฐู„ูƒ ุงู„ู„ูŠ ู‡ูˆ changing membrane fluidity ูˆู‡ุฐุง ุจูŠุญุตู„
218
00:20:08,070 --> 00:20:12,730
ุบุงู„ุจุง from methylation ุฃูˆ phospholipid ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ
219
00:20:12,730 --> 00:20:15,670
ููŠ cell membrane ุจูŠุคุฏูŠ ุฅู„ู‰ transient increase in
220
00:20:15,670 --> 00:20:19,670
cyclic AMP ู…ุทุจูˆุนุฉ
221
00:20:19,670 --> 00:20:24,810
ุจุงู„ูƒุงู„ุณูŠูˆู… influx ูˆุทุจุนุง ู‡ุฐุง ุจูŠุนู…ู„ slow down to the
222
00:20:25,280 --> 00:20:29,160
process of degranulation ูˆุจุงู„ุชุงู„ูŠ ุงู„ู€ activation of
223
00:20:29,160 --> 00:20:32,880
the adenylate cyclase ุงู„ู„ูŠ ู‡ูˆ ุจุชุญูƒู… ููŠ ุงู„ู€ cyclic AMP
224
00:20:32,880 --> 00:20:39,320
and cAMP can control the anaphylaxis
225
00:20:39,320 --> 00:20:50,340
ุทุจุนุง
226
00:20:50,340 --> 00:20:51,080
ุงู„ู€ degranulation
227
00:20:54,060 --> 00:20:59,800
Degranulated cells regenerate and synthesize the
228
00:20:59,800 --> 00:21:02,620
granules and resume their function ุทุจูŠุนูŠ ุฌุฏุง ุฅุฐุง
229
00:21:02,620 --> 00:21:05,780
ูƒุงู† ุนู…ู„ Degranulation ุชุฑุฌุน ุชูƒูˆูŠู† ุงู„ู€ granules ู…ู†
230
00:21:05,780 --> 00:21:10,320
ุงู„ุฃูˆู„ ูˆ ุฌุฏูŠุฏ ูˆุจุงู„ุชุงู„ูŠ ุจ .. it can resume their
231
00:21:10,320 --> 00:21:15,720
function easily Effector phase ุงู„ู€ symptoms of
232
00:21:15,720 --> 00:21:21,560
allergic reaction ุบุงู„ุจุง ู‡ูŠ ุนุจุงุฑุฉ ุนู† ู…ุตุงุญุจุฉ ุงู„ู€
233
00:21:21,560 --> 00:21:27,200
inflammatory mediators released ูˆุฌุงุจูˆุง ุฅู† ุงู„ู€
234
00:21:27,200 --> 00:21:30,460
inflammatory mediators ู‡ูŠ ู†ูˆุนูŠู† ูˆุงุญุฏ already
235
00:21:30,460 --> 00:21:35,680
preformed mediators ูˆุงู„ุชุงู†ูŠ newly formed mediators
236
00:21:35,680 --> 00:21:40,960
ุฃูˆ mast cell mediators ูˆู‡ู†ุดูˆู ู‡ู… ู‡ุฐุง ู‡ู… ุฒูŠ ู…ุง ุฅู†ุชูˆุง
237
00:21:40,960 --> 00:21:50,890
ุนุงุฑููŠู† ู‡ูŠ ุงู„ู€ .. ุงู„ู€ .. ุงู„ู€ mast cell ู…ุฑุชุจุทุฉ ุจุงู„ู€ antigen
238
00:21:50,890 --> 00:21:56,210
ูˆ ู„ุงุญุธูˆุง ุงู„ู€ cross linking ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ between
239
00:21:56,210 --> 00:22:04,510
receptors ู…ุน ุงู„ู€ antigen ุทุจุนุง ู…ุญุตู„ุช ู‡ุฐุง ุงู„ูƒู„ุงู…
240
00:22:04,510 --> 00:22:09,550
ุจูŠุตูŠุฑ ููŠู‡ calcium influx ูˆุจูŠุชุจู‘ุน ุงู„ู€ calcium influx
241
00:22:09,550 --> 00:22:13,890
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ degranulation ุงู„ู„ูŠ ุฒูŠ ู…ุง ุงุชูู‚ู†ุง ููŠ ู†ูˆุนูŠู†
242
00:22:13,890 --> 00:22:17,470
ู…ู† ุงู„ู€ granules ูˆุงุญุฏ already preformed ูŠุนู†ูŠ ู…ูˆุฌูˆุฏ
243
00:22:17,470 --> 00:22:25,110
ููŠ ุงู„ู€ granules ุฌุงู‡ุฒ ุฒูŠ ุงู„ู€ histamine ูˆุงู„ู€ heparin ูˆุงู„ู€
244
00:22:25,110 --> 00:22:32,230
proteases ูˆ ุงู„ู€ ECF-A ูˆ IL8 ูˆ
245
00:22:32,230 --> 00:22:37,850
other cytokines ู‡ุฐู‡ ุงู„ู…ูŠุฒุฉ ู…ูˆุฌูˆุฏุฉ ู…ุณุชุนุฏุฉ ูˆู…ุณุชุนุฏุฉ
246
00:22:37,850 --> 00:22:42,690
ููŠ ุงู„ุฎู„ูŠุฉ ูุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
247
00:22:42,690 --> 00:22:46,170
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
248
00:22:46,170 --> 00:22:46,650
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
249
00:22:46,650 --> 00:22:46,910
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
250
00:22:46,910 --> 00:22:47,070
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
251
00:22:47,070 --> 00:22:50,350
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
252
00:22:50,350 --> 00:22:56,330
ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ ุฅุตู„ุงุญู‡ุง ุจุฅู…ูƒุงู†ูƒ
253
00:22:56,330 --> 00:23:04,520
ุฅุตู„ุงุญู‡ุง ูˆุจุทู„ุนู†ุง ุงู„ู„ูŠ ู‡ูˆ Arachidonic Acid ุฃูŠ ุงุชู†ุดุท
254
00:23:04,520 --> 00:23:08,740
ุงู„ููˆุณููˆู„ุงูŠ ุจูŠุฒ ุงู†ุฒุงูŠู… ูˆุจุทู„ุน ุงู„ู€ Arachidonic Acid
255
00:23:08,740 --> 00:23:13,340
from the membrane ู„ุจุช ูˆุงู„ู€ Arachidonic Acid ุจุฏูŠู†ุง
256
00:23:13,340 --> 00:23:19,560
ู†ูˆุนูŠู† ู…ู† ุงู„ู€ product ูˆุงุญุฏ ููŠ ูˆุฌูˆุฏ ุงู„ู€ Cyclooxygenase
257
00:23:19,560 --> 00:23:25,060
ุงู†ุฒุงูŠู… ุจุฏูŠ Prostaglandin ูˆ Thromboxane A2 ูˆููŠ ูˆู„ูˆุฏ
258
00:23:25,060 --> 00:23:29,960
ุงู„ู„ูŠ ู‡ูˆ ุฃูƒุณุฌูŠู†ูŠู‡ ู…ุฏู‰ ุงู„ู„ูŠูƒูˆุชุฑูŠู† ุจุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ ู‡ูŠ
259
00:23:29,960 --> 00:23:35,440
ุงู„ู„ูŠูƒูˆุชุฑูŠู† B ูˆC ูˆD ูˆE ูƒู„ู‡ู… ุจูŠุทู„ุนูˆุง slow release
260
00:23:35,440 --> 00:23:41,000
substance are released ูˆู‡ูŠ ุงู„ู…ุณุฆูˆู„ุฉ ุนู† ูƒุซูŠุฑ ู…ู†
261
00:23:41,000 --> 00:23:49,720
ุงู„ุฃุนุฑุงุถ ุนู† ุงู„ู€ pain ูˆ ุงู„ู€ symptoms ูŠุจู‚ู‰ ููŠู‡ ู…ูˆุฏูŠูˆ ู…ุฏูŠู†ุฉ
262
00:23:49,720 --> 00:23:53,100
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
263
00:23:53,100 --> 00:23:54,620
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
264
00:23:54,620 --> 00:23:55,320
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
265
00:23:55,320 --> 00:24:00,420
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
266
00:24:00,420 --> 00:24:00,460
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
267
00:24:00,460 --> 00:24:02,820
ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ ู…ุฑุณูˆู…ูŠุฉ
268
00:24:06,250 --> 00:24:08,770
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
269
00:24:08,770 --> 00:24:09,290
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
270
00:24:09,290 --> 00:24:10,190
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
271
00:24:10,190 --> 00:24:18,130
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
272
00:24:18,130 --> 00:24:20,350
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
273
00:24:20,350 --> 00:24:21,290
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
274
00:24:21,290 --> 00:24:22,090
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
275
00:24:22,090 --> 00:24:23,990
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู†
276
00:24:23,990 --> 00:24:31,180
ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุงู† ุงู„ุจุฑููˆุชูˆ
277
00:24:31,180 --> 00:24:35,220
ุฑูŠุณุจุชูˆุฑ ููŠ ุงู„ู‡ุณุชุงู…ูŠู† ูˆุฌุฏูˆุง ุฃู†ู‡ ููŠ ุชูˆ ุฑูŠุณุจุชูˆุฑ ูˆุงุญุฏ
278
00:24:35,220 --> 00:24:38,680
ุจูŠุณู…ูˆู‡ H1 ุฑูŠุณุจุชูˆุฑ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ู€ smooth muscles
279
00:24:38,680 --> 00:24:43,940
ูˆุงู„ุงุฑุชุจุงุท ููŠู‡ ุจูŠุคุฏูŠ ู„ู€ construction and increase
280
00:24:43,940 --> 00:24:49,040
vascular permeability ุทุจุนุง construction of the
281
00:24:49,040 --> 00:24:52,180
smooth muscles ูˆู„ู…ุง ุจุชุดุฏ ุงู„ู€ smooth muscle ุจูŠุตูŠุฑ
282
00:24:52,180 --> 00:24:57,520
ููŠ vascular permeability ูˆุงู„ู€ H2 ุฑูŠุณุจุชูˆุฑ ู…ูˆุฌูˆุฏ ููŠ
283
00:24:57,520 --> 00:25:07,500
ุงู„ู€ mucus secretion ุจุดูƒู„ ุนุงู… ูˆุงู„ุงุฑุชุจุงุท ุงู„ู„ูŠ ู‡ูŠ
284
00:25:07,500 --> 00:25:13,160
ุงู„ู‡ุณุชุงู…ูŠู† ููŠู‡ ุจูŠุนู…ู„ Vascular permeability ูˆ ุจูŠุคุฏูŠ ุฅู„ู‰
285
00:25:13,160 --> 00:25:20,700
ุฒูŠุงุฏุฉ ุงู„ู€ HCL ููŠ ุงู„ู€ stomach ูˆ ู…ู† ุงู„ู€ mycosal cell of
286
00:25:20,700 --> 00:25:23,300
the stomach ู…ู† ุงู„ู€ parietal cell of AS of the
287
00:25:23,300 --> 00:25:26,860
stomach ุนุดุงู†
288
00:25:26,860 --> 00:25:37,160
ู‡ูŠ ูƒุงู† ู„ู…ุง ุชุดุชุบู„ ุนู„ู‰ ุญู…ูˆุถุฉ
289
00:25:37,160 --> 00:25:37,280
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚
290
00:25:37,280 --> 00:25:37,300
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚
291
00:25:37,300 --> 00:25:37,380
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚
292
00:25:37,380 --> 00:25:37,620
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚
293
00:25:37,620 --> 00:25:42,940
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚
294
00:25:42,940 --> 00:25:53,840
ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„ูˆู‚ ู…ุฎู„
295
00:25:55,250 --> 00:26:02,090
ุจูŠู†ู…ุง ุงู„ู€ H2 ุฑูŠุณุจุชูˆุฑ ู…ุบู„ู‚ ู…ู† ุณูŠู…ูŠุชุฏูŠู† ุฃู†ูˆุงุน ู…ุนูŠู†ุฉ
296
00:26:02,090 --> 00:26:05,690
ู…ู† ุงู„ู€ ุงู†ุชูŠู‡ุณุชุงู…ูŠู†ูƒ
297
00:26:05,690 --> 00:26:12,110
ู„ุฐู„ูƒ ูŠุฌุจ ุฃู† ูŠูƒูˆู† ู‡ู†ุงูƒ ูุฑู‚ ู…ุง ุจูŠู†ู‡ู… ุณูุงุชู†ูŠู† ู…ุฌุฑุฏ
298
00:26:12,110 --> 00:26:19,530
ู…ุฏูŠุฑ ุงู†ูู„ุงู…ุงุชูˆุฑูŠ ูŠุนู…ู„ ุฒูŠู‡ ูˆุฒูŠ ุงู„ู‡ุณุชุงู…ูŠู† ุซู… ุงู„ู€
299
00:26:19,530 --> 00:26:22,810
cytokine ูˆู‚ู„ู†ุง ููŠ ู…ุฌู…ูˆุนุฉ ู…ู†ู‡ู… ุนุจุงุฑุฉ ุนู†
300
00:26:22,810 --> 00:26:29,090
chemotactic factor ุฒูŠ DMCSF ูˆ ุงู„ู€ IL-5 ูˆ tumor
301
00:26:29,090 --> 00:26:33,790
necrosis factor Alpha ุซู… ุงู„ู€ xenophilic chemotactic
302
00:26:33,790 --> 00:26:40,750
factor ูˆ ุงู„ู€ platelet activating factor ูˆ ุงู„ู„ูŠูƒูˆุชุฑูŠู†
303
00:26:42,310 --> 00:26:46,170
ูˆู‚ุงู„ ุชู…ุงู†ูŠุฉ ูƒูŠู…ูˆุชุงูƒุณูŠ of polymorphic nuclear
304
00:26:46,170 --> 00:26:50,670
ู†ุชุฑูˆููŠู† ูƒู„ู‡ุง ุนุจุงุฑุฉ ุนู† ุฅูŠุดุŸ ุนุจุงุฑุฉ ุนู† cytokine and
305
00:26:50,670 --> 00:26:54,850
chemotactic factor which are released ุฃูŠุถุง ุณูˆุงุก
306
00:26:54,850 --> 00:26:59,070
ูƒุงู†ุช performed on newly synthesized one ู‡ูŠุจู‚ู‰
307
00:26:59,070 --> 00:27:04,130
ุงู„ูŠู…ูŠู† ุฃู† ู‡ูˆ ุนุจุงุฑุฉ ุนู† acidic proteoglycan molecule
308
00:27:04,130 --> 00:27:09,500
ุฏูˆุฑู‡ ูŠุนู†ูŠ ู…ุง ุงู„ุงู†ู‡ูŠุจุดูŠ ุฅู„ุง ุงู„ู€ coagulation ูˆู„ุง ูŠูˆุฌุฏ
309
00:27:09,500 --> 00:27:14,080
ุฏูˆุฑ ููŠ ุงู„ุงู†ูู„ุงูƒุณูŠุฒ ุงู„ู„ูŠ ุจูŠุญุตู„ ุงู„ู€ newly
310
00:27:14,080 --> 00:27:19,860
synthesized ู‚ูˆู„ู†ุง ุงู„ู„ูŠูƒูˆุชุฑูŠู† ูˆู‡ุฐูŠู† ู‡ู… ู…ุชุงุจู„ุงุช ู…ู†
311
00:27:19,860 --> 00:27:24,880
ุงู„ุงุฑุฏู†ูƒ ุฃุณุฏ ุจุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ ุงู„ู„ูŠูƒูˆุชุฑูŠู† ุจูŠ ููˆุฑ ุณูŠ ููˆุฑ
312
00:27:24,880 --> 00:27:30,200
ุฏูŠ ููˆุฑ ุงูŠ ููˆุฑ ูˆู‡ูƒุฐุง ุดูˆ ุจูŠุนู…ู„ูˆุง ู‡ุฏูˆู„ุฉ ู„ุชุณุจุจ ููŠ
313
00:27:30,200 --> 00:27:31,600
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
314
00:27:31,600 --> 00:27:33,360
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
315
00:27:33,360 --> 00:27:33,400
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
316
00:27:33,400 --> 00:27:35,500
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…
317
00:27:36,090 --> 00:27:41,950
ูˆุงู„ุณุจุจ ู‡ูˆ ุงู„ูƒุซูŠุฑ ู…ู† ุงู„ุงู†ู‡ูŠุณุชุงู…ูŠู† ุงู„ู…ู‚ุงูˆู…ุฉ ููŠ ุงู„ุจุดุฑ
318
00:27:41,950 --> 00:27:47,170
ู‡ู…ุง ุจูŠุคุฏูˆุง ุฅู„ู‰ ูˆุฏูˆุฏ ุงู„ู‚ุฒู…ุฉ ุงู„ู„ูŠ ู„ุง ูŠุฎู„ู‚ู‡ุง ุนู„ุงุฌ
319
00:27:47,170 --> 00:27:51,010
ุจูŠูƒูˆู† ููŠู‡ ู…ู‚ุงูˆู…ุฉ ุนู†ุฏ ุงู„ู…ุฑูŠุถ
320
00:27:57,240 --> 00:27:58,700
ุทุจุนุง ู‡ุคู„ุงุก ู‡ู… ู…ุตุงุฏุฑ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
321
00:27:58,700 --> 00:28:01,120
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
322
00:28:01,120 --> 00:28:02,020
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
323
00:28:02,020 --> 00:28:05,020
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
324
00:28:05,020 --> 00:28:07,060
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
325
00:28:07,060 --> 00:28:07,320
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
326
00:28:07,320 --> 00:28:07,440
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
327
00:28:07,440 --> 00:28:07,480
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
328
00:28:26,370 --> 00:28:32,510
ูˆ Vasodilator ุงู„ู„ูŠ ูŠู…ูƒู† ุฃู† ูŠุฌุนู„ู‡ ูŠุดูƒูˆูƒ ุงู„ู€ Late
329
00:28:32,510 --> 00:28:39,790
phase reaction ู‚ู„ู†ุง ุจูŠุญุตู„ ููŠ ุฎู„ุงู„ 48 ุณุงุนุฉ ูˆูŠุณุชู…ุฑ
330
00:28:39,790 --> 00:28:44,130
ููŠ ุนุฏุฉ ุฃูŠุงู… ูˆู‡ุฐู‡
331
00:28:44,130 --> 00:28:50,750
ุงู„ู€ Mediators ูƒู„ู‡ุง ุจู€ and their action ู‡ุฐู‡ ุนุจุงุฑุฉ ุนู†
332
00:28:50,750 --> 00:28:54,530
muscles ุงู„ู„ูŠ ุตุงุฑุช ู‚ุงู…ุช with degranulation ูˆู‚ุฏุช
333
00:28:54,530 --> 00:28:58,440
ุงู„ุงุฑู„ูŠุฒ Ovestamine, Serotonin, Heparin, Thromboxyl
334
00:28:58,440 --> 00:29:02,940
-A2, Prostaglandin, Leucotrin, and Cytokine ุจุชุฃุซุฑ
335
00:29:02,940 --> 00:29:05,460
ุนู„ู‰ ุงู„ู€ lymphocytes, macrophages, ุฒู†ูˆููŠู„
336
00:29:05,460 --> 00:29:09,680
ูˆู†ูŠุชุฑูˆููŠู„. ุงู†ุธุฑูˆุง ุฅู„ู‰ ู…ุง ูŠุชุฃุซุฑ ูƒู„ ู‡ุฐุง. ุนู†
337
00:29:09,680 --> 00:29:13,800
ู†ูŠุชุฑูˆููŠู„ุŒ ูƒุงู† ู‡ู†ุงูƒ ู†ูŠุชุฑูˆููŠู„ ูƒูŠู…ูˆุชุงูƒุชูƒ ูุงูƒุชูˆุฑ ุฒูŠ R8
338
00:29:13,800 --> 00:29:18,500
ุทุจุนุง ู…ุญุตู„ุชู‡ ูƒูŠู…ูˆุชุงูƒุณูŠ ู„ู†ูŠุชุฑูˆููŠู„ ูˆูุงุฌูˆ ุณุงูŠุชูˆุณูŠุฒ
339
00:29:18,500 --> 00:29:23,060
ูˆุทุจุนุง ุฏูŠ ุฌุฑุงู†ูˆู„ูŠุด ู„ู†ูŠุชุฑูˆููŠู„ ุจูŠุคุฏูŠ ู„ุฒูŠุงุฏุฉ ู„ุงุฒูˆุฒุงูŠู…
340
00:29:23,060 --> 00:29:27,230
ุงู„ุฅู†ุฒุงูŠู… ูˆุงู„ู„ูŠูƒูˆุชุฑูŠู†ูˆ ุงู„ู€ Plated Activating Factor
341
00:29:27,230 --> 00:29:33,270
ูˆุฏูˆู„ ู…ุญุตู„ุชู‡ู… ุชุดูˆ ุฏุงู…ุฌ ุซุฑู…ุจูˆูƒุณูŠู†
342
00:29:33,270 --> 00:29:39,170
A2 ูˆุณุงุนุชู‡ ูƒุงู† ุขูŠุฉ ู„ุชู„ุงุชุฉ ุฃุฑุจุน ุฎู…ุณ ูˆุซู„ุงุซุงุดุฑ ู…ุน
343
00:29:39,170 --> 00:29:43,430
ุงุฒูŠู†ูˆููŠู„ูŠูƒ ูุงูƒุชูˆุฑ ูƒูŠู…ูˆุชุงูƒุชูƒ ูุงูƒุชูˆุฑ ุทุจุนุง ุจูŠุคุฏูŠ
344
00:29:43,430 --> 00:29:50,390
ุงู„ุงุฒูŠู†ูˆููŠู„ ูƒูŠู…ูˆุชุงูƒุณูŠ ูˆุงูŠุถุง activation of ุงุฒูŠู†ูˆููŠู„
345
00:29:50,390 --> 00:29:55,280
ูˆ degranulation ูˆุงู„ู…ุญุงุตู„ุฉ ู„ูŠูƒูˆุชุฑูŠู† ุจู„ุชู„ูŠุช ุงูƒุชูุงุช
346
00:29:55,280 --> 00:30:01,680
ูุงูƒุชูˆุฑ ู‡ุณุชุงู…ูŠู†ูŠุฒ ุงุฑูŠู„ ุณุงู„ููŠุฒ ูˆุงู„ู…ูŠุฌุฑ ุจุงุณูŠูƒ ุจุฑูˆุชูŠู†
347
00:30:01,680 --> 00:30:10,080
ู†ูŠุฑูˆ ุชูˆูƒุณู† ูˆู‡ูŠู„ ู…ุงู†ุซ ุชูˆูƒุณู† ุงู„ู…ุญุงุตู„ุฉ ุชุดูˆ ุฏุงู…ุฌ ุทุจุนุง
348
00:30:10,080 --> 00:30:15,900
ุงู„ู€ both ุงูŠุฒูŠู†ูˆููŠู„ ูˆู†ูŠุชุฑูˆููŠู„ ุจูŠู‚ุฏูˆุง ุฃูˆ are brought
349
00:30:15,900 --> 00:30:23,010
into close contact with antibody coated antigen via
350
00:30:23,010 --> 00:30:29,270
Fc Receptor on these cells ุงู„ู„ูŠ ู‡ู… Receptor ู„ู„ู€ Fc
351
00:30:29,270 --> 00:30:34,410
Epsilon Receptor ูˆูŠุชู†ุชู‡ูŠู† ุจูŠุฌูˆุง ูˆุจุชู†ุดุฑุทูˆุง ู…ู† ุฎู„ุงู„
352
00:30:34,410 --> 00:30:39,250
ุงุฑุชุจุงุท ุจุงู„ู€ Receptors ุงู„ู„ูŠ ุนู„ู‰ ุณุทุญู‡ู… Release of
353
00:30:39,250 --> 00:30:43,550
cytokine ุฒูŠ 1,4,6 ูˆ Tumor Metabolosis Factor Beta
354
00:30:43,550 --> 00:30:48,150
ุจูŠุคุฏูŠ ู„ู‡ุง ุทุจุนุง ู‡ุฐุง ุงู„ู€ infiltration of T and B
355
00:30:48,150 --> 00:30:53,660
lymphocyte and macrophage ูˆู‡ูŠ ุงู„ุชู„ุงุชุฉ ูˆู…ุญุตุฑุชู‡ุง
356
00:30:53,660 --> 00:30:58,660
ุงู„ุจุฑุชูˆุณุงูŠุชูˆูƒุงูŠู… ุฑูˆุฏุงูƒุช ูˆ Antibody production ูˆ
357
00:30:58,660 --> 00:31:00,360
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
358
00:31:00,360 --> 00:31:01,160
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
359
00:31:01,160 --> 00:31:03,640
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
360
00:31:03,640 --> 00:31:06,760
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
361
00:31:06,760 --> 00:31:06,780
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
362
00:31:06,780 --> 00:31:08,060
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
363
00:31:08,060 --> 00:31:10,460
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
364
00:31:10,460 --> 00:31:18,720
ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ ู…ุงููŠ
365
00:31:18,720 --> 00:31:23,620
ู…ุงุฐุง ุทุจุนุง ุฅุฐุง ุตุงุฑ ุจูŠุตูŠุฑ ุจุนุฏ ูŠูˆู…ูŠู† ู…ู† ุงู„ู€
366
00:31:23,620 --> 00:31:28,980
sensitivity ูˆุฅุฐุง ุตุงุฑ ุชุฃุซูŠุฑู‡ ุจูŠู‚ุนุฏ ุฃูŠุงู… ุจูŠู‚ุนุฏุด ุณุงุนุฉ
367
00:31:28,980 --> 00:31:36,520
ุฃูˆ ุณุงุนุชูŠู† ุทุจุนุง ู‡ุฐุง figure ุจูŠุจูŠู† ู„ู†ุง how is the
368
00:31:36,520 --> 00:31:40,000
induction and effect of the mechanism ููŠ ุงู„ู€ type
369
00:31:40,000 --> 00:31:45,120
one ู‡ุงูŠ ุงู„ู€ antigen ุจูŠุฏุฎู„ ู…ู† ุฎู„ุงู„ ุงู„ู€ mucus membrane
370
00:31:45,120 --> 00:31:49,950
ุชุณุชู‚ุจู„ู‡ antigen presenting cell ุชุนู…ู„ ุงู„ู€ processing
371
00:31:49,950 --> 00:32:00,870
ูˆุชู‚ุฏู… ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ
372
00:32:00,870 --> 00:32:03,510
ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ
373
00:32:03,510 --> 00:32:03,610
ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ
374
00:32:03,610 --> 00:32:03,710
ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ
375
00:32:03,710 --> 00:32:06,590
ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ ุงู„ู€ ุฑูŠุณุจุชูˆุฑ
376
00:32:06,590 --> 00:32:17,570
ุงู„ุจุฑุชูˆุฑูˆ ุงู„ุจุฑุชูˆุฑูˆ ุงู„ุจุฑุชูˆุฑูˆ ุงู„ุจุฑุชูˆุฑูˆ ุงู„ุจุฑุชูˆุฑูˆ
377
00:32:17,570 --> 00:32:22,920
ุงู„ู†ูˆู„ูŠ ุณูŠู†ุชุณุงูŠุฒ ุทุจุนุง ุจูŠุตูŠุฑ ูุงุฑู…ูƒูˆู„ูˆุฌูŠูƒุงู„ ุฅูŠููƒุช ุฒูŠ
378
00:32:22,920 --> 00:32:26,180
blood vessel airway obstruction ูˆcell infiltration
379
00:32:26,180 --> 00:32:31,220
ูˆุทุจุนุง ุฃูŠุถุง ุจูŠุตูŠุฑ ููŠู‡ tissue damage ู†ุชูŠุฌุฉ ุงู„
380
00:32:31,220 --> 00:32:36,100
inflammatory and cell chemotaxis and activation ููŠ
381
00:32:36,100 --> 00:32:40,800
ุงู„ู…ุฑุงุญู„ ุทุจุนุง ุงู„ antigen ู…ู…ูƒู† directly ูŠุฌูŠ ูˆูŠุฑุชุจุท
382
00:32:40,800 --> 00:32:45,930
ุนู„ู‰ ููŠ ุงู„ู…ุฑุฉ ุงู„ุชุงู†ูŠุฉ ุงู‡ ูŠุฑุชุจุท ุนู„ู‰ ุงู„ muscle
383
00:32:45,930 --> 00:32:50,790
ุงู„ุฑูŠุฒูˆููŠู„ ุงู„ู„ูŠ ุฌุงุนุฏ ุนู„ู‰ ุณุทุญู‡ุง ุงู„ู„ูŠ ู‡ูˆ antibody IgE
384
00:32:50,790 --> 00:32:56,590
antibody ูˆุงู„ู„ูŠ ุณู…ูŠู†ุงู‡ุง sensitized cell ูˆุงู„ู…ุฑุงุญู„
385
00:32:56,590 --> 00:33:00,030
ุงู„ู…ุฎุชู„ูุฉ ุงู„ุฃูˆู„ู‰ antigen presentation ุซู… IgE
386
00:33:00,030 --> 00:33:04,010
production ุซู… muscle degranulation ุซู… clinical
387
00:33:04,010 --> 00:33:07,890
effect of
388
00:33:07,890 --> 00:33:13,700
ุงู„ู„ูŠ ู‡ูˆ re-exposure to the antigen ู‡ุฐู‡ ุงู„ู…ุฑุงุญู„
389
00:33:13,700 --> 00:33:19,640
ุงู„ู…ุฎุชู„ูุฉ ุงู„ู„ูŠ ุจุชู…ุฑ ููŠู‡ุง ู‡ุฐู‡ ุงู„ .. ุงู„ู„ูŠ ู‡ูˆ ู‡ุฐุง
390
00:33:19,640 --> 00:33:27,620
ุงู„ู†ูˆุน ู…ู† ุงู„ุญุณุงุณูŠุฉ ุทุจุนุง ู‡ุฐู‡ ู†ูุณ ุงู„ุตูˆุฑุฉ ุทูŠุจ ุงู„
391
00:33:27,620 --> 00:33:30,380
clinical consequences of allergic reaction ุดูˆููˆุง
392
00:33:30,380 --> 00:33:34,120
ุชุจูŠุนุงุช ุงู„ allergic reaction ูƒุงู†ูˆุง ุจูŠุตูŠุฑ ููŠ
393
00:33:34,120 --> 00:33:40,350
allergic rhinitis ูˆุณู…ูŠู†ู‡ุง high fever ุฃูˆ ุทุจุนุง ุฅุฐุง
394
00:33:40,350 --> 00:33:43,890
ูƒุงู† ุฏุฎู„ ุนู† ุทุฑูŠู‚ ุงู„ุฃุดูŠุงุก ุงู„ู„ูŠ ู‡ูˆ ุฃูˆ food allergy
395
00:33:43,890 --> 00:33:50,190
ุฅุฐุง ูƒุงู† ุฃูƒู„ู†ุงู‡ุง ุฃูˆ atopic dermatitis if there is
396
00:33:50,190 --> 00:33:58,330
skin contact ุฃูˆ ุฃุฒู…ุฉ ู…ู† ุฎู„ุงู„ ุงู„ุฃุดูŠุงุก ุงู„ุฃุฑูˆุงุญ soul
397
00:33:58,330 --> 00:34:04,480
ุทุจุนุง ู‡ูŠ ุงู„ุฃู†ูˆุงุน ุงู„ู…ุฎุชู„ูุฉ ุงู„ู„ูŠ ู…ู…ูƒู† ุชุตูŠุฑ ู‡ุฐู‡ ู…ู…ูƒู†
398
00:34:04,480 --> 00:34:08,360
ุชุคุฏูŠ ุฅู„ู‰ anaphylactic shockุŒ ูˆanaphylactic shock ูŠุนู†ูŠ ู…ูˆุช ู…ู…ูƒู†ุŒ
399
00:34:08,360 --> 00:34:11,880
if untreated it can cause death clinical test
400
00:34:11,880 --> 00:34:17,300
ุจูŠุนู…ู„ูˆุง skin prick test ูˆุทุจุนุง ุจูŠุงุฎุฏูˆุง ู…ูŠู„ูˆุชุฑ ู…ูˆุชู‡
401
00:34:17,300 --> 00:34:24,260
ุจุฃู†ุชูŠุฌูŠู† ูˆุจุญู‚ู†ู‡ ุชุญุช ุงู„ุฌู„ุฏ ูˆุจูŠุณุชู†ูˆุง ุนู„ูŠู‡ ุชุงู†ูŠ ูŠูˆู…
402
00:34:24,260 --> 00:34:27,910
ุจูŠุด .. ูˆุจูŠุฏูˆุฑูˆุง ุนู„ู‰ ุงู„ wheel and flare response ูˆ
403
00:34:27,910 --> 00:34:32,150
ุงู„ู€ wheel and flare ู‡ูŠ ุนุจุงุฑุฉ ุนู† redness ูˆedema ุจุชุตูŠุฑ
404
00:34:32,150 --> 00:34:42,930
ุฎู„ุงู„ ุนุดุฑ ุฅู„ู‰ ุฎู…ุณุฉ ุนุดุฑ ุฏู‚ูŠู‚ุฉ ุงู‡ ุฃู†ุง ุจุนุฑู ุงู„ู€ PK ุฎู„ุงู„
405
00:34:42,930 --> 00:34:49,090
ุงู„ู„ูŠ ู‡ูˆ ุฃุฑุจุน ูˆุนุดุฑูŠู† ุณุงุนุฉ ู…ุง ุนู„ูŠู†ุง ุงู„ู€ wheel and flare
406
00:34:49,090 --> 00:34:50,190
ุงู„ู€ wheel and flare ุงู„ู€ wheel and flare ุงู„ู€ wheel and flare ุงู„ู€
407
00:34:50,190 --> 00:34:51,990
wheel and flare ุงู„ู€ wheel and flare ุงู„ู€ wheel and flare ุงู„ู€ wheel and flare
408
00:34:51,990 --> 00:34:52,350
wheel and flare ุงู„ู€ wheel and flare ุงู„ู€ wheel and flare ุงู„ู€
409
00:34:52,350 --> 00:34:57,030
wheel and flare ุจุงู„ุทุจุน ู‡ุฐุง ุงู„ู€ covalent coupling of
410
00:34:57,030 --> 00:35:02,690
allergen to insoluble matrix ุจูŠูƒูˆู† quotient ู…ุงุดูŠ
411
00:35:02,690 --> 00:35:10,290
ุงู„ู€ allergen ุจูŠุจู‚ู‰ beads ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุฃูˆ ุงู„ู„ูŠ ู‡ูˆ
412
00:35:10,290 --> 00:35:15,090
stick ุฏุจ into a sample of patient serum ุญุทู‡ุง ููŠ
413
00:35:15,090 --> 00:35:20,010
ุฅูŠู‡ุŸ ููŠ patient serum allowed to bind specific
414
00:35:20,010 --> 00:35:26,390
antibody for allergen ุจุนุฏ ุฐู„ูƒ ูˆุด ุงู„ู€ stick ุงู„ู„ูŠ ู‡ูˆ
415
00:35:26,390 --> 00:35:32,030
radio labelled antibody specific for IgE is added
416
00:35:32,030 --> 00:35:37,290
ุจุนุฏ ุฐู„ูƒ the amount of radio activity bound is a
417
00:35:37,290 --> 00:35:41,270
measure of the amount of specific IgE antibody in
418
00:35:41,270 --> 00:35:47,800
the serum sample ูŠุนู†ูŠ ู‡ุฐู‡ ุจูŠุณุชุฎุฏู…ูˆุง ููŠู‡ุง ุงู„ู„ูŠ ู‡ูˆ ู„ูˆ
419
00:35:47,800 --> 00:35:54,040
ุชุฎูŠู„ู†ุงู‡ุง ุนุจุงุฑุฉ ุนู† beads ุฃูˆ ุนุจุงุฑุฉ ุนู† stick ุฒูŠ ุงู„ู„ูŠ
420
00:35:54,040 --> 00:36:04,000
ู‡ูˆ ุงู„ู€ pregnancy test ู…ุงุดูŠ ุจูŠูƒูˆู† ุงู„ู€ stick ู‡ุฐู‡ ุนู„ูŠู‡ุง
421
00:36:04,000 --> 00:36:07,980
ุงู„ู€ allergen ุนู„ูŠู‡ุง ุงู„ู€ allergen ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ antigen
422
00:36:07,980 --> 00:36:13,570
ุงู„ู„ูŠ ุจุฏู‡ ูŠุนู…ู„ ุญุณุงุณูŠุฉ ู†ุญุทู‡ุง ููŠ ุงู„ู€ patient serum ุนุดุงู†
423
00:36:13,570 --> 00:36:16,770
ู†ุฏูˆุฑ ุฅุฐุง ูƒุงู† ููŠ ุนู†ุฏู‡ antibody for that allergen
424
00:36:16,770 --> 00:36:20,990
ูˆู†ุณูŠุจู‡ุง ู†ุฏูŠู‡ุง ูุฑุตุฉ ุฅู† ุงู„ู€ antibody ูŠุฑุชุจุท ู„ูŠู‡ุง ุจุงู„ู€
425
00:36:20,990 --> 00:36:24,490
allergen ุงู„ู„ูŠ ุตุงุฑ ููŠ antibody ุฏูŠ ุนุงุฏุฉ ู…ุงุณูƒ ููŠ ุงู„ู€
426
00:36:24,490 --> 00:36:30,090
allergen ุฅุฐุง ู…ูˆุฌูˆุฏุฉ ุงู„ู€ antibody ุจุนุฏูŠู† ู†ุถูŠู radio
427
00:36:30,090 --> 00:36:34,030
labelled anti antibody ูŠุนู†ูŠ antibody specific for
428
00:36:34,030 --> 00:36:39,940
the IgE ู…ุงุดูŠ ุฅุฐุง ู…ูˆุฌูˆุฏ ุงู„ู€ antibody ุงุฑุชุจุท ุจูŠุตูŠุฑ ููŠู‡
429
00:36:39,940 --> 00:36:45,900
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ second antibody ุจุฏู‡ ูŠุฑุชุจุท ููŠู‡ ูˆูŠุตูŠุฑ ููŠู‡
430
00:36:45,900 --> 00:36:51,360
radio labeling ู‡ุฐู‡ ุทุจุนุง can be measured ูˆุจู†ุดูˆู
431
00:36:51,360 --> 00:36:54,100
ุงู„ู„ูŠ ู‡ูˆ it will be proportional to the
432
00:36:54,100 --> 00:36:57,860
concentration of IgE antibody in the serum sample
433
00:36:57,860 --> 00:37:03,980
intervention environmental intervention
434
00:37:06,860 --> 00:37:13,980
ุฃูุถู„ ุฃู† ุฃู‚ูˆู… ุจุงุณุชุฎุฏุงู… ุงู„ู€ broncho
435
00:37:13,980 --> 00:37:18,620
dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator
436
00:37:18,620 --> 00:37:20,620
dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator
437
00:37:20,620 --> 00:37:21,060
dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator
438
00:37:21,060 --> 00:37:23,320
dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator
439
00:37:23,320 --> 00:37:24,440
dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator ุงู„ู€ broncho dilator
440
00:37:24,440 --> 00:37:27,780
dilator ุงู„ู€ broncho dilator
441
00:37:27,780 --> 00:37:31,520
dilator ุงู„ู€ broncho dilator
442
00:37:31,520 --> 00:37:31,800
dilator
443
00:37:34,580 --> 00:37:37,040
ู‡ุฐู‡ ู‡ูŠ ุงู„ุนู„ุงุฌุงุช ุงู„ู„ูŠ ุจุชุฏุฎู„ immunological
444
00:37:37,040 --> 00:37:42,000
intervention ุจูŠุนู…ู„ูˆุง hypersensitization ู„ู„ู…ุฑูŠุถ ูƒูŠ
445
00:37:42,000 --> 00:37:46,360
ุจุชุชู… ู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ by injecting the patient with
446
00:37:46,360 --> 00:37:50,580
increasing doses of allergen ุดูˆูŠุฉ ุดูˆูŠุฉ ุจูŠุนุทูˆุง ุฃูƒุซุฑ
447
00:37:50,580 --> 00:38:01,190
ู…ู† dose of allergen ู„ู„ู…ุฑูŠุถ ุจุชุญูˆู„ ุงู„ู€ antibody ู„ู€ IgG
448
00:38:01,190 --> 00:38:06,790
ูˆุจุงู„ุชุงู„ูŠ ุชุฎู„ุต
449
00:38:06,790 --> 00:38:11,870
ุงู„ุญุณุงุณูŠุฉ ุงู„ู€ neutral increase in level of IgG
450
00:38:11,870 --> 00:38:17,640
followed by gradual decrease on continued therapy due
451
00:38:17,640 --> 00:38:21,520
to induction of tolerance or to switch from Th2
452
00:38:21,520 --> 00:38:28,800
to Th1 ุจูŠุจู‚ู‰ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ุฅู†ู‡ ุฒูŠ ุฒูŠุงุฏุฉ ููŠ ุงู„
453
00:38:28,800 --> 00:38:33,100
concentration ูˆ IgG ุจุชุจุนู‡ุง ู…ู† ุฎู„ุงู„ ุงู„ู€ repeated
454
00:38:33,100 --> 00:38:37,740
injection decrease in the concentration ูˆุงู„ุณุจุจ ููŠ
455
00:38:37,740 --> 00:38:43,520
ุฐู„ูƒ ุฅู…ุง ู„ุฃู†ู‡ ุตุงุฑ ููŠ tolerance ู„ู€ ุงู„ู€ antigen ุงู„ู„ูŠ
456
00:38:43,520 --> 00:38:48,740
ุฏุฎู„ุงู†ู†ุง ุฏุฎู„ู†ุง ุจู€ doses ู…ุฎุชู„ูุฉ ุฃูˆ ุฅู†ู‡ ุตุงุฑ ููŠ
457
00:38:48,740 --> 00:38:54,340
switching ู…ู† ู…ุฏุงู„ุฉ Th2 ู„ู€ Th1 ูˆุจุงู„ุชุงู„ูŠ
458
00:38:54,340 --> 00:39:06,060
ุตุงุฑ ููŠ ุงู„ู„ูŠ ู‡ูˆ ุจุทู„ ููŠ IgE production ุงู„ุงุณุชุฎุฏุงู…
459
00:39:06,060 --> 00:39:11,440
ุงู„ู„ูŠ ู‡ูˆ immunized anti IgE monoclonal antibody ูˆุฏู‡
460
00:39:11,440 --> 00:39:19,180
ุจูŠุนู…ู„ ุงู„ุชูŠ ู„ุง ุชุชุนุงู…ู„ ู…ุน ุงู„ู€ IgE bound to mast and
461
00:39:19,180 --> 00:39:29,300
basophils ุจุฑุถู‡ ู‡ุฐุง ุฃุญุฏ ุงู„ุงุณุชุฎุฏุงู…ุงุช ุฃูˆ
462
00:39:29,300 --> 00:39:34,720
use of cytokine which can shift from Th2 to Th
463
00:39:34,720 --> 00:39:42,760
1 response ุฃูˆ ุงุณุชุฎุฏุงู… Anti-Cytokine ุฒูŠ Anti-IL-4
464
00:39:42,760 --> 00:39:48,260
IL-4 ุทุจุนุง responsible for IgE production ูุจู†ุนู…ู„
465
00:39:48,260 --> 00:39:58,460
class switching in B cell Anti-Cytokine ูˆ Cytokine
466
00:39:58,460 --> 00:40:04,770
receptor antagonist ุจู†ุนู…ู„ blocking ู„ู„ู€ receptor ุฃูˆ
467
00:40:04,770 --> 00:40:07,470
administration of chemically altered allergen
468
00:40:07,470 --> 00:40:11,630
which suppress a primary or established IgE
469
00:40:11,630 --> 00:40:17,930
response ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
470
00:40:17,930 --> 00:40:18,990
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
471
00:40:18,990 --> 00:40:25,010
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
472
00:40:25,010 --> 00:40:25,590
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
473
00:40:25,590 --> 00:40:26,290
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
474
00:40:26,290 --> 00:40:26,310
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
475
00:40:26,310 --> 00:40:29,030
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ
476
00:40:29,030 --> 00:40:33,230
ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ูƒ
477
00:40:34,770 --> 00:40:40,610
ุจุฃูƒุซุฑ ู…ู† ุทุฑูŠู‚ุฉ ู…ู…ูƒู† ูŠุณุชุฎุฏู…ูˆู‡ุง to treat this
478
00:40:40,610 --> 00:40:46,590
patient ุงู„ู€ protective ุฏูˆุฑ ู„ู€ IgE ู‡ูˆ ุจุฑุนุง protective
479
00:40:46,590 --> 00:40:51,470
ุฅู„ุง ุฅู†ู‡ ู‡ู†ุง ู‡ูˆ ุฃู…ู„ ุฃู† ุฏู‡ ู…ุดุงูƒู„ ุทุจุนุง ุงู„ู€ response to
480
00:40:51,470 --> 00:40:56,470
many parasitic war favor the induction of IgE his
481
00:40:56,470 --> 00:40:58,530
to mean another mediator associated with
482
00:40:58,530 --> 00:41:02,930
anaphylactic response ูŠุชู… ุฅุทู„ุงู‚ู‡ุง ููŠ ุฅุฌุงุฑุฉ ุงู„ู€
483
00:41:02,930 --> 00:41:07,230
wormุŒ ุงู„ู€ antigenุŒ ุงู„ู€ cross-linkingุŒ ุงู„ู€ IgEุŒ ุนู„ู‰
484
00:41:07,230 --> 00:41:13,330
ุงู„ุฎู„ุงูŠุง ุงู„ู€ mast ูˆุงู„ู€ basophil ูˆุงู„ู€ eosinophil. ุทุจุนุง
485
00:41:13,330 --> 00:41:18,410
ุงู„ุงุฑุชุจุงุท ุจูŠุคุฏูŠ ุฅู„ู‰ ุฒูŠุงุฏุฉ ุงู„ู€ permeabilityุŒ ุจุณุจุจ
486
00:41:18,410 --> 00:41:25,850
ุงุณุชุนู…ุงู„ ุงู„ู€ releaseุŒ ูˆู‡ุฐุง ุจูŠุคุฏูŠ ุฅู„ู‰ ุงู„ู€ IgE
487
00:41:25,850 --> 00:41:28,790
-Antibody ููŠ ู…ูˆู‚ุน ุงู„ู€ worm infestation.
488
00:41:40,310 --> 00:41:44,150
ุงู„ุฅูŠูˆุณูŠู†ูˆููŠู„ ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช ุงู„ู€ IgG ูˆุงู„ุนุถู„ุงุช IgG
489
00:41:44,150 --> 00:41:46,530
ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ูˆุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG
490
00:41:46,530 --> 00:41:49,570
ูˆุงู„ุนุถู„ุงุช IgG
491
00:41:49,570 --> 00:41:49,790
ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ูˆุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG
492
00:41:49,790 --> 00:41:50,330
ูˆุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ูˆุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท
493
00:41:50,330 --> 00:41:50,430
ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG
494
00:41:50,430 --> 00:41:52,550
ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท
495
00:41:52,550 --> 00:41:59,770
ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG
496
00:41:59,770 --> 00:42:03,570
ู…ุฑุชุจุท ุจุงู„ุนุถู„ุงุช IgG ู…ุฑุชุจุท ุจุงู„ุนุถู„
497
00:42:06,920 --> 00:42:12,540
contact ูˆุทุจุนุง ู‡ุฐุง ูŠุฌุนู„ ุงู„ุงู†ุชุฌุงุฑ
498
00:42:12,540 --> 00:42:15,620
ุงู„ุงู†ุชุจุงู‡ูŠ ุนู„ู‰ ุณุทุญ ุงู„ู€ worm ูˆู‡ุฐุง ุจู†ุดุชุช complement
499
00:42:15,620 --> 00:42:21,460
ูˆุจุงู„ุชุงู„ูŠ ูŠุชุฎู„ุต ู…ู† ุงู„ู€ worm ู†ุจุฏุฃ ู„ูˆ ู„ุฎุตู†ุง ู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ
500
00:42:21,460 --> 00:42:26,480
ู‡ู… ูŠู‚ูˆู„ูˆุง ุฅู† ุงู„ู‡ูŠุณุชุงู…ูŠู† ูˆุขุฎุฑ ู…ุฏูŠุงุชุฑูŠู† ุดูˆ ุจูŠุนู…ู„ูˆุงุŸ
501
00:42:26,480 --> 00:42:29,120
ูŠู‚ูˆู„ูˆุง ุจูŠุนู…ู„ูˆุง anaphylactic shock ุดูˆ ุงู„ุณุจุจุŸ ูŠู‚ูˆู„ูˆุง
502
00:42:29,120 --> 00:42:34,630
ุจูŠุตูŠุฑ ููŠู‡ ุฒูŠุงุฏุฉ ุทุจุนุง ูŠูˆู… ู…ุง ุชุฎุด ุงู„ู€ worm ู…ุงุดูŠ ู‡ูŠุตูŠุฑ
503
00:42:34,630 --> 00:42:38,630
ููŠ IgE ุงู„ู€ cross linking ุนู„ู‰ ุณุทุญ ุงู„ู€ muscle
504
00:42:38,630 --> 00:42:42,110
ูˆุงู„ุจูŠุฒูˆููŠู„ ูู‡ูŠุตูŠุฑ ููŠ degradation ูˆ IgE ูˆู‡ุณุชุงู…ูŠู†
505
00:42:42,110 --> 00:42:49,690
ูˆู…ุฌู…ูˆุนุชู‡ ุทุจุนุง ุจุงู„ุฅุถุงูุฉ ุฅู„ู‰ ุงู„ู€ IgG ุงู„ู‡ุณุชุงู…ูŠู† ุงู„ุฑูŠู„ูŠุฒ
506
00:42:49,690 --> 00:42:53,250
ู…ุตูŠุฑ ููŠ IgG Antibody production ููŠ ู…ู†ุทู‚ุฉ ุงู„ุญุฏุซ
507
00:42:53,250 --> 00:42:57,150
ุทุจุนุง ุงู„ู€ IgG ุจุงู„ู…ู†ุงุณุจุฉ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ receptor ุนู„ู‰ ุณุทุญ
508
00:42:57,150 --> 00:43:03,070
ุงู„ุฅูŠูˆุฒูŠู†ูˆููŠู„ ู†ุชูŠุฌุฉ ุฃูŠุถู‹ุง ุงู„ู€ chemotactic
509
00:43:03,070 --> 00:43:12,990
factor ุงู„ู„ูŠ ุจุชูุฑุฒ ุจุชุตู„ ุฅู„ู‰ ู…ู†ุทู‚ุฉ ุงู„ู€ worm ูˆ ุจุชุทุจุท
510
00:43:12,990 --> 00:43:19,810
ููŠู‡ ู…ู† ุฎู„ุงู„ ุงู„ู€ IgG receptor ุงู„ู„ูŠ ุนู„ู‰ ุณุทุญู‡ุง ุงู„ู„ูŠ
511
00:43:19,810 --> 00:43:25,970
already ุจูŠูƒูˆู† ู…ุงุณูƒ ููŠ ุงู„ู€ worm ูˆุจุงู„ุชุงู„ูŠ ุตุงุฑ ููŠ
512
00:43:25,970 --> 00:43:30,290
ุงู„ุฅูŠูˆุฒูŠู†ูˆููŠู„ ู…ุงุณูƒ ุจุงู„ู€ worm ู…ู† ุฎู„ุงู„ ู…ู† ุฎู„ุงู„
513
00:43:30,290 --> 00:43:33,730
ุงู„ู€ IgG Antibody ูุจุงู„ุชุงู„ูŠ ุจุชุนู…ู„ Degranulation
514
00:43:33,730 --> 00:43:40,190
ูˆุจุชุนู…ู„ ุงู„ุชุฎู„ุต ู…ู† ุงู„ู€ Parasites ู„ุงุฒู… ููŠ ุงู„ู€ Express
515
00:43:40,190 --> 00:43:47,090
Low Affinity to FC Receptor by IgE ูˆุทุจุนุง ู‡ุฐุง ุจูŠุคุฏูŠ
516
00:43:47,090 --> 00:43:54,030
ุฅู„ู‰ ุงุฑุชุจุงุท of these cells ุฃูˆ ุฃูŠ cells ุนู„ู‰ ุณุทุญ IgE
517
00:43:54,030 --> 00:43:59,830
antibody IgE ุจูŠูƒูˆู† ู‚ุงุนุฏ ุนู„ู‰ ุณุทุญ ู…ูŠู†ุŸ ุนู„ู‰ ุณุทุญ ุงู„ู€
518
00:43:59,830 --> 00:44:06,530
worm ุงู„ู€ major basic protein released by eosinophilic
519
00:44:06,530 --> 00:44:12,870
granules ุชุนู…ู„ ูƒูˆุชูŠู†ุฌ ู„ู€ Surface of worm ูˆู‡ุฐุง ุจูŠุคุฏูŠ
520
00:44:12,870 --> 00:44:20,330
ุฅู„ู‰ ุงู„ู€ death of worm and its eventual explosion
521
00:44:20,330 --> 00:44:26,210
from the body. All component of type 1 reaction
522
00:44:26,210 --> 00:44:31,270
combine to perform this protective function ูƒู„ู‡ุง
523
00:44:31,270 --> 00:44:36,490
beneficial effects suggest that the wide range of
524
00:44:36,490 --> 00:44:41,520
response ุงู„ุฐูŠ ูŠุชุนู„ู‚ ุจุงู„ุงู†ุชุจุงุฏ ุงู„ู€ IgE ู‚ุฏ ูŠุชุนู„ู‚
525
00:44:41,520 --> 00:44:48,420
ุจุงุณุชุฎุฏุงู… ุชุฌุงุฑุจ ุงู„ุงู†ุชุจุงุฏ ุงู„ู‡ุฑู…ูˆู†ูŠ ูŠุนู†ูŠ ุงู„ุฌุงู†ุจ
526
00:44:48,420 --> 00:44:52,380
ุงู„ุญุณู† ููŠ ู‡ุฐุง ุงู„ู†ูˆุน ู…ู† ููŠ ุฅูุฑุงุฒ ุฃูˆ ููŠ ุชูƒูˆูŠู†
527
00:44:52,380 --> 00:44:59,700
ุงู„ุงู†ุชุจุงุฏ ุฃู†ู‡ it can ู†ู‚ุฏุฑ ู†ุชุฎู„ุต ู…ู† ุฃู†ู‡ it's
528
00:44:59,700 --> 00:45:04,580
released during worm infestation ูˆุจุงู„ุชุงู„ูŠ ูŠูˆู… ู…ุง
529
00:45:06,190 --> 00:45:12,710
ูŠูุฑุฒ ููŠ ูˆุฌูˆุฏ parasites ุงู„ู…ุญุตู„ุฉ ู…ู† ุฎู„ุต ุฃูˆ ุชุฎู„ุต ู…ู†
530
00:45:12,710 --> 00:45:19,350
ุงู„ู€ parasites ูˆู‡ูŠ
531
00:45:19,350 --> 00:45:29,830
ุทุจุนุง ู‡ุงูŠ ู…ูŠูˆูƒูˆุฒุง ุงู„ู€ membrane ุฏุฎู„ ุงู„ู€ worm ู…ุงุดูŠ ูˆ
532
00:45:29,830 --> 00:45:30,350
ุทุจุนุง
533
00:45:34,660 --> 00:45:40,820
ุฏุฎู„ ุงู„ู€ Antigen ุชุจุนู‡ ู„ุฌู‡ุฉ
534
00:45:40,820 --> 00:45:48,620
IgE ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุณุทุญ ุงู„ุฎู„ุงูŠุง ูˆุฃูŠุถู‹ุง ุจูŠุฒูŠุฏ ููŠ ูˆุฌูˆุฏ ุงู„ู€
535
00:45:48,620 --> 00:45:52,720
worm ูู‡ูŠ ุงู†ุชุจู‡ุช ุจุงู„ู€ Antigen ุชุจุน ุงู„ู€ worm ู‚ุฏ ุฃุฏู‰ ุฅู„ู‰
536
00:45:52,720 --> 00:45:56,940
ู†ุดุงุทู‡ ูุตุงุฑ ููŠู‡ Degradation ู…ู† ุถู…ู†ู‡ุง ุงู„ู‡ุณุชุงู…ูŠู†
537
00:45:58,530 --> 00:46:02,970
ุงู„ุฅูŠูˆุฒูŠู†ูˆููŠู„ ูƒูŠู…ูˆุชุงูƒุชูƒ ูุงูƒุชุฑ ูˆู†ูŠุชุฑูˆููŠู„ ูƒูŠู…ูˆุชุงูƒุชูƒ
538
00:46:02,970 --> 00:46:07,850
ูุงูƒุชุฑ ุทุจุนู‹ุง ูƒู„ู‡ู… ุจูŠุตู„ูˆุง ุฅู„ู‰ ู…ู†ุทู‚ุฉ ุงู„ุญุฏุซ ู‡ุจูŠุฒูˆุฏูˆุง
539
00:46:07,850 --> 00:46:13,030
ุจูŠุฒูŠุฏ ุงู„ู€ permeability to
540
00:46:13,030 --> 00:46:18,670
IgG and white blood cell ุชุจุฏุฃ ุชุทู„ุน ู‡ุฐู‡ ุงู„ู€ antibody
541
00:46:18,670 --> 00:46:22,170
ู…ุฑุฉ
542
00:46:22,170 --> 00:46:27,380
ุซุงู†ูŠุฉ ู…ู† ุงู„ู€ mucosal membrane ุนู„ู‰ ุงู„ู€ worm ุจุชุฑุชุจุท ุจุงู„
543
00:46:27,380 --> 00:46:32,580
worm ูˆุจุชูŠุฌูŠ ุงู„ู€ neutrophil ูˆุงู„ู€ eosinophil ุจุชุฑุชุจุท
544
00:46:32,580 --> 00:46:38,660
ุจุงู„ู€ antibody ู…ู† ุฎู„ุงู„ ุงู„ู€ FC portion ูˆุจุชุฎู„ุตู†ุง ู…ู† ุงู„ู€
545
00:46:38,660 --> 00:46:47,080
Parasites ู‡ุฐุง ุชู„ุฎูŠุต ู„ูƒูŠู ุจูŠุชู… ุงู„ุชุฎู„ุต ู…ู† ุงู„ู€ parasites
546
00:46:47,080 --> 00:46:52,380
ู…ุฑุฉ ุซุงู†ูŠุฉ ู‡ูŠ ุงู„ู€ parasites ุจูŠุฎุด ู…ู† ุฎู„ุงู„ ุงู„ู€ mucosal
547
00:46:52,380 --> 00:46:57,060
membrane ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ antigen ุฃูˆ ุงู„ู€ parasites ุจู†ุงุก
548
00:46:57,060 --> 00:47:04,160
ููŠ ุงู„ุชุดูˆุนุฉ ุฃูˆ ููŠ ุงู„ู€ intestine ู…ุงุดูŠ ูุจุชุชู„ู‚ู ูˆุทุจุนุง
549
00:47:04,160 --> 00:47:08,340
ุจุฑุชุจุท
550
00:47:08,340 --> 00:47:15,090
ุจุงู„ู€ ุนู„ู‰ ุณุทุญ ุงู„ุนุถู„ุฉ ุจูŠุตูŠุฑ ููŠู‡ Degranulation ุจูŠุตูŠุฑ
551
00:47:15,090 --> 00:47:18,170
ููŠู‡ Release ู„ู€ eosinophil chemotactic factor ู„ู†ูŠุชุฑูˆููŠู„
552
00:47:18,170 --> 00:47:23,650
ูˆู†ูŠุชุฑูˆููŠู„ ุจูŠุตู„ูˆุง ุจูŠุฒูŠุฏูˆุง ููŠ ู…ู†ุทู‚ ุทุจุนุง ููŠ ุงู„ู€ blood
553
00:47:23,650 --> 00:47:26,990
vessels ุทุจุนุง ู‡ุฐุง ุจูŠุฒูŠุฏ ุงู„ู€ permeability ูุจุชุทู„ุนูˆุง
554
00:47:26,990 --> 00:47:33,360
ุจุฑุง ู‡ูˆ ุงู„ู€ IgE/IgG Antibody ุงู„ู„ูŠ ุจูŠุทู„ุน ุทุจุนุง ู…ุง ุฒุงู„
555
00:47:33,360 --> 00:47:37,320
ุตุงุฑ ููŠ increase ู„ู„ู€ permeability ุนู…ู„ุชู‡ุง ุจุฑุง ูˆุจุฑุชุจุท ุจูŠู‡ุงุด ุจุงู„
556
00:47:37,320 --> 00:47:41,080
worm ุทุจุนุง ู‡ุงูŠ ุงู„ู€ antibody ุงุฑุชุจุท ุจุงู„ู€ worm ู…ู† ุฎู„ุงู„
557
00:47:41,080 --> 00:47:45,080
ุงู„ู€ fabrication ุงู„ู„ูŠ ูุงู„ุช ุงู„ู€ FC portion ู„ู‡ receptor
558
00:47:45,080 --> 00:47:49,940
ุนู„ู‰ ุณุทุญ ุงู„ู€ eosinophil ูˆุงู„ู€ neutrophil ุงู„ู„ูŠ ุจูŠุชู†ุดุทูˆุง
559
00:47:49,940 --> 00:47:53,460
ุจูŠุชุฑุชุจุทูˆุง ูˆ ุจูŠุชู†ุดุทูˆุง ูˆ ุจูŠุนู…ู„ูˆุง degradation ูˆ
560
00:47:53,460 --> 00:48:00,180
ุจูŠุฎู„ุตูˆู†ุง ู…ู† ุงู„ู‡ุงุด ู…ู† ุงู„ู€ worm ู‡ุฐุง ุงู„ู†ูˆุน ุงู„ุฃูˆู„ ู…ู†
561
00:48:00,180 --> 00:48:06,140
ุงู„ุญุณุงุณูŠุฉ ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ ู‡ูˆ ุงู„ู€ antibody which is also
562
00:48:06,140 --> 00:48:11,220
antibody mediated cytotoxic
563
00:48:11,220 --> 00:48:12,040
reaction